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ABSTRACT
Cancer remains the second most common cause of death in the United States. It is therefore
imperative that a lot of effort be put into finding a cure for this dreadful disease that shows no
discrimination, and virtually anybody is at risk of developing the disease.
Chapter 1 introduces basic facts about cancer and the available treatments, including PDT and
BNCT. Our focus will be on these two bimodal therapies, which form the basis of my research
work, which involves the synthesis of potential sensitizers to be used either in PDT or BNCT or
both.
In Chapter 2, I discuss the synthesis of thienyl- appended porphyrins, which have been found to
absorb at longer wavelengths. This is favorable for PDT applications. In addition to this I
introduce carborane cages to the porphyrin system to obtain compounds that have high
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B

concentrations and therefore potential boron delivery agents in BNCT. In this chapter I will also
discuss the photophysical and biological studies of the porphyrins that I have synthesized.
Chapter 3 reports the synthesis of various carborane substituted oligothiophenes. Using a base,
the closo carboranes are converted to the open nido cages. Insertion of different metals into these
cages results in the synthesis of sandwich-type metalla-bis(dicarbollide) compounds, which are
further electropolymerized to give the corresponding polymers. Both photophysical and
biological studies of the oligothiophenes are carried out to establish their potential as
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B

delivery agents in BNCT.
Finally, in chapter 4, I discuss the synthesis of new disubstituted tetrabenzoporphyrins (TBPs). In
order to increase selectivity of the compounds towards tumor cells, we conjugate the compounds
to the polyamine, spermine, to the macrocycle.

xi

CHAPTER 1: INTRODUCTION
1.1 Cancer Basics
Cancer is characterized by uncontrolled growth and spread of abnormal cells (Figure 1-1). When
the spread of these abnormal cells is not prevented, it can lead to death1. Cancer is the second
most common cause of death after heart diseases. According to the most recent statistics from the
American Cancer Society, it was estimated that there would be more than 1.5 million new cancer
cases in the year 2010. In addition to this, it was projected that there would be more than 500,000
lives lost as a result of cancer. This translated to about 1,500 deaths a day2. Most cancer types are
named after the organ or cell they originate from. In the United States, the most common types
of cancer include bladder cancer, breast cancer, colon and rectal cancer, endometrial cancer,
kidney (renal cell) cancer, leukemia, lung cancer, melanoma, non-hodgkin lymphoma, pancreatic
cancer, prostate cancer and thyroid cancer. Cancer can further be classified into four stages, I-IV,
depending on the extent of the primary tumor and the extent to which it has spread in the body.
Staging is critical in cancer diagnosis since it will determine the mode of treatment that will be
used3. The most common types of treatment for cancer include surgery, chemotherapy and
radiation therapy. Before the development of chemotherapy and radiation therapy, the only
treatment that was available was the surgical removal of tumors. Development of the
chemotherapies began in the 1940s, with the use of nitrogen mustards the drugs of choice.
Nitrogen mustards are strong alkylating agents that have the ability to add alkylating groups onto
DNA bases, resulting in the destruction of cancer cells4. Since then, there has been the
development of many different drugs that have been used in chemotherapeutics. The modes of
action of most of these drugs involve the inhibition of DNA replication or interference with its
function as a way of destroying cancer cells5. A more recent approach has been the use of
1

Figure 1-1. Uncontrolled growth of cancer cells6
oncolytic viruses which selectively enter neoplastic cells and replicate in the cells leading to their
destruction7. Despite cancer cells being different from normal cells, they still share the same
DNA and major metabolic pathways. As a result, the traditional drugs that attack DNA
replication or cell division in cancer cells, can also attack normal cells. This results in serious
side effects such as bone marrow and gastrointestinal toxicity which in some cases can prove to
be life threatening4. As a result, there has been the need for the development of less invasive
procedures with fewer side effects. A lot of focus has therefore been put on two relatively new
bimodal therapies, photodynamic therapy (PDT) and boron neutron capture therapy (BNCT).
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1.2 Photodynamic Therapy (PDT)
The concept of combining light with a chemical agent dates back to approximately 3000 years
ago. Ancient Egyptians and Indians used this photochemistry for restoration of pigment in
vitiligo patients8. In modern science however, PDT was first reported over 100 years ago by
Hermann von Tapiener and his student Oscar Raab, when they discovered that illumination of
microbial cultures in presence of acridine resulted in cell death. It was not until 1960 that it was
reported that neoplastic tissues in patients fluoresced under light after administration of a
photosensitizer9. In cancer therapy therefore, visible light, a light sensitive drug (photosensitizer)
and oxygen are all combined. This leads to production of toxic species which in turn destroy
tumor tissue10. When the photosensitizer absorbs light, it is excited to a short-lived excited
singlet state (S1) (see Figure 1-2). Through intersystem crossing, this molecule can convert to the
excited triplet state (T1). To explain the cell destruction process, two different mechanisms, type
I and type II, are usually invoked. In type I reactions, the photosensitizer in its excited triplet
state generates free radicals by electron or proton transfer, while in the type II mechanism,
singlet oxygen (1O2) is produced by energy transfer. In both reactions, oxygen is seen as a major
mediator of cell destruction11.
In the first step in the process of photodynamic therapy, the photosensitizer is administered either
orally, topically, or intraveneously (see Figure 1-3). This is followed by a period of incubation,
which allows for the photosensitizer to accumulate in the tumor cells. During this time, the ratio
of the concentration of the drug in tumor cells to that of normal cells is such that the tumor cells
have considerably higher concentrations. Depending on the type of photosensitizer, the
incubation period could range from a few hours to a couple of days. The tumor is then irradiated
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by a source of light with the desired wavelength. The toxic species that are generated cause the
desired cell destruction10.

Figure 1-2: Mechanism of PDT12: 1)Absorption of light 2)Fluorescence 3) Intersystem Crossing
4) Phorphorescence 5) Hydrogen radical or electron transfer 6) Singlet Oxygen Production

Figure 1-3. The process of photodynamic therapy13

4

As discussed earlier, only subcellular structures that are labeled by the photosensitizers are
typically damaged by the photodynamic process. Therefore, the intracellular localization of
photosensitizers plays a major role in PDT efficiency. A lot of research has been carried out to
determine the mechanism for the preferential retention of photosensitizers by tumors14. Although
these mechanisms are not fully understood, it has been widely accepted that serum proteins are
mainly responsible for transportation of photosensitizers throughout the body. It has been shown
that upon administration into the body, photosensitizers associate mainly with low-density
lipoproteins (LDL). Several in vitro and in vivo studies have shown that there is an over
expression of LDL receptors in tumor cells than in normal cells. LDLs therefore play a major
role in the delivery of hydrophobic and/or ampiphilic photosensitizers to cancerous cells 15.
Therefore when designing a photosensitizer for PDT, it is crucial to keep in mind the affinity it
has for LDL.
1.3 Classes of Photosensitizers
Photosensitizers can be classified according to their chemical structure. Table 1-1 lists the
different families of photosensitizers. The first category consists of compounds that essentially
are dyes. Pthalocyanines and naphthalocyanine dyes belong to this group, and they have a lot of
potential as PDT photosensitizers. The second category consists of compounds with a
chlorophyll and bacterio chlorophyll platform. As expected, these compounds, just like
chlorophyll, have excellent photosensing properties. This group is comprised of chlorins,
purpurins and bacteriochlorins. The final category has a porphyrin platform. This is perhaps the
most promising group of all, and is evidenced by the number of clinical photosensitizers that are
based on this platform16(see Table 1-1). While there are many compounds that can act as
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photosensitizers, very few are commercially available. Table 1-216 lists various clinical
photosensitizers that are currently available.
Table 1-1. The categories of photosensitizers16
Porphyrin Platform

Chlorophyll and Bacteriochlorophyll
Platform

Dyes

HpD

Chlorins

Phthalocyanines

HpD-based

Purpurins

Napthalocyanines

BPD

Bacteriochlorins

ALA
Texaphyrins

Table 1-2: Photosensitizers clinically available for PDT16
Drug

Substance

Manufacturer

Cancer Treated

Photofrin®

HpD

Axcan Pharma, Inc

Esophageal, Colon and
rectal,brain, head, neck

Visudyne®

Vertiprofin
BPD

Novartis
Pharmaceuticals

Age related macular
degeneration

Metvix®

M-ALA

PhotoCure ASA

Skin, neck, head

Levulan®

ALA

DUSA Pharmaceuticals,
Inc.

Skin, bladder, actinic keratosis

Antrin®

Lutexaphyrin

Pharmacylics

Arterial vascular disease,
breast
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Table 1-2 continued
Drug

Substance

Manufacturer

Cancer Treated

Foscan®

Temoporfin

Biolitec Pharma Ltd.

Cutaneous lesions,
esophageal, head,
neck

LS11

Talaporfin

Light Science

Ongoing clinical
studies

Photochlor

HPPH

RPCI

Barrett‟s esophagus,
lung

Photosens®

Phthalocyanine

General Physics
Institute

Cutaneous and
endobronchial
lesions, lip, pharynx,
larynx, tongue, head,
neck

Figure 1-4: Examples of Drugs used in PDT
7

Figure 1-4 cont‟d

As seen, most of the photosensitizer drugs currently available are based on a porphyrin platform.
This can be attributed to a number of key photophysical, photochemical, and biological
properties that they possess. Studies have shown that porphyrins absorb strongly in the visible
region of the optical spectrum, they are fluorescent, and generally non- toxic in the dark. In
addition to this, they have been found to have a high affinity for serum proteins thereby
enhancing their selectivity for tumors. They have been found to exhibit chemical stability, both
as free or metal-complexed compounds while retaining their in vivo tumor-localization. Finally,
8

they have been shown to localize in subcellular structures, lysosomes, endoplasmic reticulum,
mitochondria and golgi apparatus17. Even though PDT provides a non-invasive procedure in the
cure of cancer, there are some drawbacks that are associated with the process. The first major
hurdle that needs to be overcome is the fact that normal cells are also destroyed in the process of
killing the tumor cells. This can be addressed by finding ways of improving the selectivity of the
photosensitizers in the tumor. It has also been reported that after this procedure, some patients
experience photosensitive skin, which could last from a few hours to several weeks. This is
brought about by the photosensitizer not clearing fast enough from the body18. Evidently, a lot of
work still needs to be done to improve this promising relatively new cancer therapy.
1.4 Boron Neutron Capture Therapy (BNCT)
As mentioned earlier, surgery, chemotherapy, and radiation therapy are conventional approaches
to the treatment of cancer. In case of solid tumors, surgery is the preferred method for removal of
the tumor. However there is always a bit of uncertainty as to whether all the cancerous cells were
removed or not. As a result, there is always the possibility of recurrence of the tumor.
Chemotherapy and radiotherapy offer alternative means of destroying cancer cells. In the case of
chemotherapy, the major drawback is that the destructive effects of the drugs used are not limited
to the tumor cells only, as normal cells are also destroyed. In radiotherapy, the radiation used to
destroy tumors is usually so strong that normal cells are also killed. To make matters worse, in
both chemotherapy and radiotherapy, the toxic effects on normal cells are irreversible19.
Evidently, there has been a need to develop better strategies to combat cancer. This has led to the
development of bimodal therapies, which include the use of radiation sensitizers20, gene
therapy21, photodynamic therapy (PDT)17 and neutron capture therapies (NCT)22.
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1.5 Fundamental Properties of Nuclides
Neutrons are uncharged nuclear particles which have an atomic mass of 1 and energy of
0.025eV. Their most important property with respect to radiation is that they only react with
nuclei and not electrons. This interaction proceeds via scattering and absorption. NCT is
therefore based on the ability of some nuclides, both radioactive and non-radioactive to absorb
thermal or slow neutrons. These nuclear events liberate lethal particles that possess large
amounts of energy. A measure of the probability of neutrons being captured by a nuclide is given
by its cross section, which is expressed in barn (1 barn = 10-24 cm2). Table 1-319 lists the nuclides
with high capture cross sections.
Table 1-3: Cross section values of selected nuclides for thermal neutrons
Nuclide
6

Li

Cross section
(barn)
942

Nuclide
151

Eu

Cross section
(barn)
5800

10

B

3838

155

Gd

61000

11

B

0.0055

197

Au

98.7

Naa

32000

157

Gd

255000

Coa

1900

164

Dy

1800

19800

184

I

6000

199

Xea

2600000

230

Pma

10600

235

Sm

42000

241

H

0.332

24

Li

940

31

0.18

12

C

0.0034

32

S

0.004

14

N

1.81

Cl

43.6

22
58

113

Cd

126 a
135
148

149
1
6

Os

3000

Hg

2000

Paa

1500

Ua

580

Pua

1010

Mg

0.052

P

35
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Table 1-3 continued
Nuclide
16
17
23
a

Cross section (barn)

O
O

Na

Nuclide

0.000178

39

0.235

40

0.4

56

Cross section (barn)

K

0.0043

Ca

0.4

Fe

2.63

Radioactive

The capture cross section and subsequently the reactions arising from them is different for each
nuclide. Therefore, even for isotopes of the same elements, the capture cross sections greatly
differ. When compared to the capture cross section values of tissue elements, (Table 1-419), it can
be seen that these values are at least 2 orders of magnitude greater.
The capture cross-section, however, is just one aspect that is considered when choosing nuclides
for use in NCT. Another very important point to take into consideration is whether the toxic
radiation produced during the fission process is confined in the cell. If this is not achieved, then
it beats the whole purpose of using NCT as a therapeutic procedure. Early development of NCT
saw 235U and 6Li as potential nuclides for neutron capture. However, it was soon discovered, that
235

U compounds were generally toxic to the body tissues19, 23, and 6Li being an alkali metal,

under biological conditions, its compounds would readily be broken down to lithium cations19. In
addition to its high capture cross section, studies have shown that when irradiated with lowenergy thermal neutrons,

10

B yields high linear energy transfer α particles and recoiling 7Li

nuclei24 as shown is Scheme 1-1. These fragments have mean free pathways of travel in tissue
(5-9μm) which is approximately equivalent to the diameter of mammalian cells. This means that
they can bring about confined biological damage through ionization19, 25. In addition to this, 10B
can take part in reactions that lead to the synthesis of different compounds which have
remarkably stable linkages with other atoms, like carbon, nitrogen, and oxygen21. Based on all
11

these attractive properties, a lot of effort has been put into development of BNCT, with the
primary focus being on the treatment of high- grade gliomas and either cutaneous primaries or
cerebral metastases of melanoma, and most recently, head, neck and liver cancer25a.

Scheme 1-1: Fission reactions that occur upon boron capture of neutrons
Successful treatment using BNCT depends on the selective delivery of the sensitizers to the
tumor and the possibility of achieving sufficiently high endocellular boron concentration24a, 24c.
Studies have shown that the amount of boron necessary for effective BNCT is between 15 and
30μg of 10B per gram of tumor, depending on its exact location within the tumor24b. As
expected, the required concentration of
10

10

B for effective BNCT decreases as the position of the

B nuclei is changed from the external cell wall to the cytoplasm to the nucleus of the cell22d.

Approximately 2% of all cancer deaths are caused by primary cerebral tumors, with about 13,000
people dying each year in the Unites States2, 26. In 1951, Dr. William H. Sweet, a neurosurgeon,
suggested the use of BNCT in treatment of brain tumors, in particular, glioblastoma
multiforme19, 27. The initial clinical trials were not successful mainly due to inadequacies in the
neutron beams, and the boron compounds that were used, which offered no selectivity to tumor
cells. There was however renewed interest in the therapy after more encouraging results by Dr.
Hiroshi Hatanaka for malignant gliomas28 and those of Dr. Yukata Mishima for malignant
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melanoma19, 29. The process of treatment using BNCT starts by directing a beam of neutrons
towards a patient‟s head. These neutrons rapidly lose energy as they pass through tissue, by
elastic scattering. Consequently, they are captures by
converted to 11B atoms for a very short time

10

B atoms, which are in turn excited and

10-12 seconds). This is followed by fission of 11B

to produce α particles, 7Li recoil nuclei and gamma rays. The α particles produced are
responsible for the selective destruction of tumor cells31 (Figure 1-4).
1.6 Boron Delivery Agents
For BNCT to be successful, not only must there be a sufficient number of
selectively accumulated in the tumors, but the concentration gradient of

10

10

B atoms that are

B atoms between the

tumors and surrounding normal cells must be large30. The priority for the last

50 years has

therefore been the development of boron delivery agents for BNCT. For a boron delivery agent
to be considered successful, it must exhibit low toxicities in normal tissue, with high tumor
uptake and high tumor/brain and tumor/blood concentration ratios (> 3-4: 1). In addition to this,
the agent must be able to supply

10

B concentrations between 10 - 30μg

10

B per gram of tumor.

Finally, during BNCT, there should be rapid clearance of the agent from blood and normal
tissues, while maintain the concentrations in tumor cells31. To date, only two boron- containing
drugs have been used clinically for BNCT of brain tumors, (L)-4-dihydroxy-borylphenylalanine
(BPA) and sodium mercaptoundecahydro-closo-dodecaborate (BSH) (Figure 1-5). These drugs
have been established to be safe, although they are not the ideal boron delivery agents25a, 31.
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Figure 1-4: The process of boron neutron capture therapy in treatment of brain tumors32

Figure 1-5: BNCT compounds that have undergone clinical trials

A lot of research work has been put into developing boron rich compounds for BNCT. Figure 16 show some BNCT agents that have been synthesized. These include compounds 9 and 10
which have caborane cages linked to nucleosides, and they have both shown promise in animal
models. The trimethoxyindole 11 has shown promise in vitro studies, while porphyrin 12 has
shown good tumor selectivity19, 22c, d.
14

Our research work focuses on the synthesis, characterization, photophysical and biological
studies of compounds that are potential PDT and BNCT agents. In one project, our main focus is
the introduction of thiophene groups at the meso position of the porphyrin macrocylce (Scheme
1-2). The first and obvious reason for this is to extend the conjugation, and therefore shift the
wavelength of absorption to longer wavelength. The second reason is based on the fact that
thiophene rings are very stable chemically, and many different reactions can be on the free αcarbon of the ring. In fact, one of the modifications that we perform is the introduction of
carboranes to the porphyrin system via the free α-carbon of the thiophene. This introduces many
attractive properties to the system due to the carborane, and it makes the compounds potential
agents for both PDT and BNCT.

Figure 1-6: Compounds that have been synthesized as potential BNCT agents

15

Scheme 1-2: Synthesis of thienyl-appended porphyrins
In the second project, we synthesize carborane appended oligothiophenes (Scheme 1-3). Not
only can these compounds be used in BNCT because of the presence of the carborane ring, but
also because of their small size we anticipate that they will readily cross the blood brain barrier
(BBB) to facilitate treatment of brain tumors. In addition to this, we prepared several metal
complexes of the oligothiophenes, which were further electropolymerized to form
polythiophenes. These polymers have potential applications in medicine and material science.

Scheme 1-3: Synthesis of carboranyl functionalized thiophenes
The third project focuses on synthesis of tetrabenzoporphyrins (TBP) (Scheme 1-4), which
belong to the family of π-extended porphyrins. This group of porphyrins absorb at longer
wavelength due to their extended conjugation. As potential photosensitizers for PDT, these
compounds are expected to have good selectivity for tumor cells. To enhance their selectivity,
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we introduce polyamine chains to the system. We specifically use spermine, which is found in
mammalian cells and has been found to take part in key roles in cellular functions.

Scheme 1-4: Synthesis of tetrabenzoporphyrins
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CHAPTER 2: SYNTHESIS OF THIENYL-APPENDED PORPHYRINS FOR
PDT AND BNCT
2.1 Introduction
For centuries, porphyrins have drawn much attention in the science community due to their wide
range of applications in the fields of medicine, biochemistry, biology, and chemistry. This can be
attributed to their fascinating chemical, physical, and spectroscopic properties1. It is therefore not
surprising that in the last century, several Nobel prizes were awarded in the field of tetrapyrrole
science2. Porphyrins are aromatic macrocycles made up of four “pyrrole- type” rings joined by
four methine carbons3. In the UV-Visible spectrum, they are characterized by the presence of an
intense Soret band1 at 400 nm and several weaker bands, found between 450 nm and 800 nm.
Porphyrins contain 22 π-electrons, of which 18 are involved in the delocalization pathway, see
Figure 2-1. Trans-NHs are the most favored tautomeric forms, while the cis-NH tautomers are
thought to be intermediates in a NH-migration mechanism4.

Figure 2-1: Delocalization Pathway of Porphyrins

Because of their many applications, much focus has been directed towards porphyrin synthesis,
which involves the arrangement of different substituents about the periphery of the macrocycle.
Generally speaking, the electronically most reactive sites at the periphery of the porphyrin
macrocycle are the 5, 10, 15 and 20 positions, which are designated as the meso positions.
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However, in the presence of bulky reactant species, the β-pyrrolic 2, 3, 7, 8, 12, 13, 17 and 18
positions are the preferred reaction sites4(Figure 2-1). Therefore there are two distinct types of
substituents at the porphyrin periphery, the β-substituted porphyrins and meso-substituted
porphyrins, with the former having a close resemblance to naturally occurring porphyrins (Figure
2-2). Meso-substituted porphyrins have gained popularity due to their ease of synthesis, as well
as the ability to design elaborate and highly sophisticated groups at the meso position. As a
result, they have found applications as biomimetic models and also form an integral part in
materials science1. Several synthetic methods for meso-substituted porphyrins have been
developed, and these include, the Rothemund, Adler and Lindsey methods.

Figure 2-2: Three types of porphyrins
2.2 Methods for Porphyrin Synthesis
Synthesis of meso-porphyrins was initiated by Rothemund in 19355.

He carried out the

syntheses by reacting different aldehydes with pyrroles at very high temperatures. The most
notable porphyrin synthesized using this method was tetramesitylporphyrin (H2TMP). This was
obtained by reaction of mesitaldehyde and pyrrole in presence of pyridine solvent, at 180oC for
48 h. It was found that the methyl groups in FeII(TMP) prevented dimer formation upon
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oxygenation6 . Despite several variations by different research groups7, this method has not
received much application. This is largely due to the low overall yields obtained.
The Adler method was developed by Adler, Longo, and co-workers in the mid 1960s8. This
method basically requires the use of acidic solvents at reflux conditions in an open atmosphere.
Of the three acids used (propionic acid, acetic acid and acidified benzene) propionic acid is the
most preferred leading to overall yields of the porphyrins, ranging between 20 and 40%1. This is
obviously better than the Rothemund method. In addition to the high yields, another attractive
feature of this method is the fact that the porphyrin product can often crystallize out of the cooled
acidic solvent. A major drawback however, is the limit in the types of aldehydes that can be used
in this synthesis. Many aldehydes with substituents that are sensitive to acids cannot be used to
prepare porphyrins using this method, and as a result, extra steps of protection and deprotection
of the substituents have to be employed9. Both the Rothemund and Adler methods have
limitations in their applications, in part due to the harsh reaction conditions that are necessary for
porphyrin synthesis. This in turn affects the yields of the final product. Secondly, these two
methods do not present a rational method of accessing porphyrins, especially those, with two,
three or four distinct meso-substituents. There was clearly a need to develop a new method that
could not only accommodate a wide range of functional groups, but could also lead to a variety
of porphyrins with different number of distinct substituents.
In the early 1980s, Lindsey and co-workers developed the Lindsey protocol which facilitated the
synthesis of porphyrins under mild conditions. This method takes advantage of the highly
reactive aldehyde and pyrrole starting materials, which do not require harsh conditions to react.
The mild conditions include condensation of the aldehyde and pyrrole in the presence of an acid
catalyst, normally trifluoroacetic acid (TFA) or BF3.OEt2, at room temperature to form a
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porphyrinogen intermediate. This step is followed by the addition of an oxidant, usually pchloranil or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), to afford the more stable
aromatic porphyrin10. The major disadvantage here is that dilute concentrations of aldehyde and
pyrrole are required to minimize the competition between oligomerization of pyrromethanes and
cyclization to give the porphyrinogen11(Scheme 2-1). This means that when running large scale
synthesis of porphyrins, one has to handle large amounts of solvents. In addition to this, the
purification step involves column chromatography, which can be cumbersome1.

Scheme 2- 1: Mechanism of porphyrin formation
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2.3 Thienyl- substituted Porphyrins
Reports on porphyrins with 5-membered heterocycles, such as pyrrole, furan and thiophene, as
substituents at the meso position are scarce12. However, meso-tetrathienyl porphyrins have
incited much interest due to their use as models for energy transfer reactions as well as for their
conductivity13. In 1968, Triebs and co-workers reported the synthesis of the first thienyl
substituted porphyrin. This was achieved using the Rothemund method and the porphyrin was
obtained in 9% yield14. Torréns and co-workers and Bhyrappa and Bhavana later prepared the
same porphyrin using the Adler-Longo method, with the latter reporting a yield of 14%13, 15.
Since then, most studies on this group of porphyrins have adapted the Lindsey protocol, mainly
due to the mild reaction conditions involved in the synthesis which the thienyl groups can
withstand16. Despite the fact that the photophysical and electronic properties of thienyl
porphyrins have been studied, there appears to be inconsistencies in describing the effect of the
thienyl ring on the electronic properties of the porphyrin molecules16a. Compared to the
corresponding tetraphenyl-porphyrin, thienyl-porphyrins show red-shifted absorption bands. In
addition to this, the shift increases with increased number of thiophene rings. For a long time, it
was accepted that this red shift in absorption was due to inductive effects of the thiophene rings.
This arose from the expectation that the small ring size of thiophene would be almost co-planar
with the porphyrin macrocycle. However, it was found that the dihedral angle formed between
the porphyrin plane and the thienyl ring was greater in metal complexed thienyl porphyrins,
compared to metal-complexed tetraphenyl- porphyrins. This means that the effective conjugation
between the thiophene ring and the porphyrin macrocycle in the thienyl-porphyrin is small13.
Studies carried out by Gupta and Ravikanth12, 17 showed that the shift was rather due to a greater
π-delocalization of thienyl-porphyrins brought about by a strong resonance interaction between
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the porphyrin macrocycle and the thienyl group(s). In general, the introduction of thienyl
group(s) on the porphyrin macrocycle allows extension of the π-conjugated system. This in turn
imparts fascinating electrochemical properties, making these systems ideal building blocks for
not only linear porphyrin arrays, but also supramolecular assemblies. To date, thienyl- polymers
have been shown to exhibit higher electrochemical stability than any other porphyrin
polymers16a.
2.4 Synthesis of trans- Substituted Porphyrins
Meso-substituted porphyrins possessing substituents in a trans-configuration have been used as
building blocks in the preparation of a wide range of systems. There are two ways in which these
compounds can be prepared. The first is a mixed aldehyde condensation of pyrrole and two
different aldehydes. This procedure affords up to six different porphyrins, with trans-substituted
porphyrins present as 12.5% of the total, and cis-substituted porphyrin present as 25% of the
total. The second and preferred method of preparation of trans-substituted porphyrins involves
the condensation of a dipyrromethane and an aldehyde, also known as the MacDonald [2 + 2]
condensation (Scheme 2-2). This method provides a rational approach to the synthesis of transsubstituted porphyrins with its success relying on the optimization of reaction conditions in order
to minimize scrambling1, 18. Scrambling refers to the formation of different products following
the initial protonation of dipyrromethane by acid catalyst, whereby a highly reactive species is
generated. The mechanism of scrambling is illustrated in Scheme 2-319.
In our research, we focus on the synthesis of meso thienyl-porphyrins, with a trans
configuration. We use the MacDonald [2 + 2] condensation to prepare the trans substituted
porphyrins because not only is this method expected to afford better yields than mixed aldehyde
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condensations, but it will also make the purification of the porphyrins obtained much easier. We
anticipate that these

Scheme 2-2: MacDonald 2+2 Condensation

Scheme 2-3: Scrambling of dipyrromethane in the MacDonald[2+2] condensation19
systems will exhibit rich electrochemical and possibly biological properties that will make them
ideal for both PDT and BNCT. Furthermore, we carry out chemical polymerization on some of
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the porphyrins, which we expect to lead to polymers with fascinating properties for different
applications.

2.5 Results and Discussion
We began the synthesis with preparation of dipyrromethane, DP-1. This was achieved by
reacting thiophene-2-carbaldehyde with a large excess of pyrrole in the presence of TFA catalyst
to afford DP-1 in 64% yield20as illustrated in Scheme 2-4.

Scheme 2-4: Synthesis of DP-1
DP-1 was recrystallized from DCM. The molecular structure of DP-1 is shown in Figure 1. The
structure is seen to be non-planar. The –NH groups are facing away from each other, with the
central carbon atom, C10-C5-C6 and C10-C5-C4 having an angle of 111.68o and 112.01o
respectively. The thiophene ring is found to be smaller in size compared to the pyrrole ring, as
seen from the C13-S1-C10 bond, 91.53o, compared to C1-N1-C4, 109.80o. In addition to this, the
S-C bonds (S1-C13, 1.6524Å and S1-C10, 1.7212 Å) are found to be longer than N-C bonds
(N1-C1 = 1.3767 Å, N1-C4 = 1.3770 Å and N2-C6 = 1.3681 Å, N2 = 1.3716 Å). This can be
attributed to an atom size effect, where S has a larger covalent radius compared to N.
Using Lindsey‟s protocol, we carried out condensation reactions using different aldehydes, to
obtain PP1, PP2, PP3, PP4, PP6, PP7 and PP8 in yields between 18% and 56% (see Scheme 25). Reaction conditions had to be optimized to minimize “scrambling” which would have
resulted in more than one product. As can be seen from Table 2-1, the yields ranged between
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18% and 56%. PP1 recorded the highest yield. This is expected because only one porphyrin can
be obtained from this reaction. During the purification of PP3 and PP4, it was observed that in
both cases, 2 other products were obtained (see Scheme 2-5).

Figure 2-3: X-ray structure of DP-1
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Scheme 2-4: Synthesis of PP1-PP7

Table 2-1: List of Porphyrins synthesized and the yields
Porphyrin
PP1

R

% yield
56%

PP2

44%

PP3

27%

PP4

20%

PP5

20%

PP6

21%

PP7

18%
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These were confirmed using NMR and MS experiments. Despite efforts to optimize conditions,
by changing the ratios of the starting reagents, and purging the reaction solutions with argon for
longer periods, these products were still available. The minor products in both cases were easily
purified by silica gel chromatography.

Scheme 2-5: Condensation reaction‟s minor products, PP3’, PP4’, PP3” and PP4”.
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Table 2-2: Percentage yields for minor products PP3’, PP4’, PP3” and PP4”
Porphyrin

% Yield

PP3’

8%

PP4’

5%

PP3”

6%

PP4”

3%

Starting with thiophene-2-carbaldehyde, we carried out bromination reaction using one
equivalent of Br2 to obtain thiophene 1. Reaction of 1 with large excess of pyrrole afforded DP-2
in 67% yield. DP-2 was condensed with 3,5-ditertbutylbenzaldehyde using Lindsey‟s method to
afford PP5. The initial attempt to synthesize PP5 included the direct bromination of PP3 using
NBS. This however, gave a mixture of products, brominated at both the α and β positions of the
thiophene ring. Separation of the brominated products by silica gel chromatography proved to be
difficult, and this led to low yields of the product. Better yields were obtained using the strategy
outlined in Scheme 2-6.
Unlike the case in PP3 and PP4, no porphyrin minor products in the synthesis of PP6 and PP7
were observed. The side products that were obtained could not be assigned structures using the
obtained

S data. A possible reason for this could be that there was “scrambling” during the

reaction process, and this led to formation of polypyrroles.
We prepared metal-porphyrin complexes by inserting Zn and Cu metals inside the free bases,
using Zn(OAc)2 and Cu(OAc)2 respectively. This afforded the corresponding metal complexes in
quantitative yields. To obtain the Zn-porphyrin complexes, the free bases and excess amount of
Zn(OAc)2 were dissolved in MeOH/DCM (1:3) and allowed to stir at room temperature for 24 h.
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Scheme 2-6: Synthesis of PP5

Purification of the products was achieved by use of silica gel chromatography using DCM as
eluent. In the case of Cu-porphyrin complexes, the free bases and excess amounts of Cu(OAc)2
were dissolved in MeOH/DCM (1:3) and stirred overnight at room temperature, and then
allowed to reflux for 4 hours to push the reaction to completion. Similarly, purification was
achieved by silica gel chromatography using DCM for elution (see scheme 2-7).
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Scheme 2-7: Synthesis of MPP1-MPP7

Table 2-3: Percentage yields for metal-porphyrin complexes
Zn-Porphyrin

% Yield

Cu-Porphyrin

% Yield

ZnPP1

54%

CuPP1

71%

ZnPP2

98%

CuPP2

94%

ZnPP3

53%

CuPP3

21%

ZnPP4

41%

CuPP4

71%

ZnPP5

62%

CuPP5

59%

ZnPP6

98%

CuPP6

21%

ZnPP7

72%

CuPP7

56%

As stated earlier, we were interested in synthesizing porphyrins for application in BNCT. Boroncontaining porphyrins were therefore synthesized as shown in schemes 2-9, 2-10, 2-14 and 2-17.
The deprotection of methoxy groups on PP4 was performed using excess BBr3 to give PP8 in
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87% yield21. Through a nucleophilic opening of the dioxane ring by the phenolate groups, PP8
was conjugated with compound 222, which was synthesized from commercially available
COSAN23. Purification of the final product was achieved by column chromatography using 1:1
EtOAc/Hexane to afford PP9 in 60% yield.

Scheme 2-7: Synthesis of Compound 2

Scheme 2-8: Deprotection of PP4 to give PP8
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Scheme 2-9: Synthesis of PP9

PP10 was synthesized from commercially available 3,5-dimethylbromobenzene. Bromination of
3,5-dimethylbromobenzene with NBS in presence of BPO, a radical initiator, gave 324.
Compound 3 reacted with 1-lithium-2-methyl-o-carborane, which was prepared in situ, to give
dicarboranylbromobenzene, 4, in 60% yield24. Reaction of 4 with n-BuLi followed by dry DMF
and acid hydrolysis afforded dicarboranylbenzaldehyde 5, in 55% yield24. Finally, aldehyde 6
was condensed with DP-1 to afford PP10 in 6% yield (see Scheme 2-10).
In an attempt to synthesize PP11, we started with commercially available 2-ethynylthiophene, as
shown in Scheme 2-11. This compound was reacted with decarborane in presence of ethyl
sulfide under reflux to afford 6 in 53% yield25. Attempts to introduce a formyl group at position
5 of the thiophene ring using n-BuLi and dry DMF and also using the Vilsmeier-Haack
reaction26 conditions were unsuccessful. This could be as a result of the strong electronwithdrawing character of the o-carborane unit which facilitates the metalation of the carborane
C-H group as shown by Equation 2-127. In addition to this, it has been shown that closocarboranes undergo degradation in the presence of DMF27b, 28.
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Scheme 2-10: Synthesis of PP10

Equation 2-1: Metalation of the o-carborane C-H group

The synthesis strategy was changed so that we started with thiophene-2-carbaldehyde. This
compound was brominated with Br2 to afford 87% of compound 129. Compound 1 was reacted
with TMSA in a Sonogashira coupling reaction, in the presence of PdCl2(PPh3)2 and CuI
catalysts to afford 43% of compound 730. Deprotection of 7 using K2CO3 afforded 8 in 87%
yield31. An attempt to add the carborane ring to compound 8 using a similar procedure described
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in Scheme 2-11 was unsuccessful. Attempts to protect the aldehyde using 1,2-ethanedithiol, as
described in literature, also proved to be difficult, as a result of formation of products that were
difficult to purify.

Scheme 2-11: Attempted introduction of formyl group on thiophene ring

Compound 8 was then condensed with excess pyrrole in presence of TFA catalyst to afford DP3 in 23% yield. Because of the low yield obtained for DP-3 we decided to synthesize the
dipyrromethane directly from compound 7. This was achieved by reacting 7 with excess pyrrole
in presence of TFA catalyst to afford DP-4 in 63% yield. Deprotection of the trimethylsilane
group using K2CO3 afforded DP-3 in 78% yield31. Finally reaction of DP-3 with decaborane
afforded DP-5 in 51% yield. Condensation of DP-5 with 3,5-ditertbutylbenzaldehyde afforded
PP11 in 34% yield. From the MS data obtained on the other fractions obtained during
purification, no other porphyrins were obtained. However, we detected presence of unreacted
starting aldehyde and dipyrromethane.
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Scheme 2-12: Attempted incorporation of carborane on Compound 8

Scheme 2-13: Synthesis of DP-3
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Scheme 2-14: Synthesis of PP11

The first attempt in the synthesis of PP12 similarly started with commercially available 5bromo-2,2'-bithiophene (see Scheme 2-15). This compound was reacted with TMSA under
Sonogashira coupling reaction conditions, with PdCl2(PPh3)2 and CuI as the catalysts, to afford 9
in 47% yield30. Deprotection of the trimethylsilane group was achieved by reacting 9 with
K2CO3 to afford 10 in 80% yield31. Using similar conditions described earlier for introduction of
carborane, 11 was obtained in 73% yield25. Attempts to introduce an aldehyde functional group
at this point were unsuccessful.
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Scheme 2-15: Attempted introduction of formyl functional group on Compound 11.

Bromination of [2,2'-bithiophene]-5-carbaldehyde using Br2 afforded 89% of compound 1232
(Scheme 2-16). Reaction of 12 with TMSA under Sonogashira conditions afforded 37% of 1330.
Condensation of 13 with excess pyrrole afforded 65% of DP-6. This was followed by
deprotection of the trimethylsilane group to obtain DP-7 in 73% yield31. Reaction of DP-7 with
decaborane under reflux afforded 55% of DP-825. DP-8 was condensed with 3,5ditertbutylbenzaldehyde to afford 8% of PP12.

Scheme 2-16: Synthesis of DP-8
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Scheme 2-17: Synthesis of PP12

Synthesis of DP-9 was achieved by reaction of [2,2‟-bithiophene]-5-carbaldehyde with excess
pyrrole in presence of TFA. This afforded the target product in 64% yield, see Scheme 2-18. DP9 was then condensed with 3,5-ditertbutylbenzaldehyde and 3,5-dimethoxybenzaldehyde using
the Lindsey method to afford PP12 and PP13 in 21% and 18% yields, respectively (see Scheme
2-19).

Scheme 2-18. Synthesis of DP-9
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Scheme 2-19: Synthesis of PP13 and PP14

Table 2-4: Percentage Yields for PP13 and PP14

Porphyrin

% Yield

PP13

21%

PP14

18%

We attempted to polymerize PP5 using Sonogashira coupling reaction conditions as shown in
Scheme 2-20. We reacted PP5 with commercially available 1,4-diethynylbenzene. Unfortunately
no polymer was obtained. MS showed that the starting reagents were recovered. It is clear that
the reaction conditions should be optimized. This can be achieved by either reacting for a longer
time or by heating at higher temperatures, or by changing the catalyst used in the reaction.
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Scheme 2-20: Attempted polymerization of PP5

2.6 Photophysical Studies
The maximum wavelengths of absorptions and molar extinction coeffecients for PP1-PP9 in
toluene and DMF are listed in Tables 2-5 and 2-6. Compared to TPP, the absorption bands of
thienyl-porphyrins are slightly bathochromically shifted by 3-14 nm, with the biggest shift being
observed in the cobaltabarborane containing, PP9. These shifts indicate that replacing the sixmembered phenyl ring with a five membered thienyl ring, significantly alters the electronic
properties of the porphyrin, which leads to a greater π-delocalization of the porphyrin into the
thienyl group by resonance interaction33. A study of the Zn- complexes of the thienyl-porphyrins,
further indicated that the metal complexes in general showed red-shift Soret bands relative to the
free bases. This observation is consistent with what has been observed in literature13. This can be
as a result of change in geometry when the Zn metal is inserted inside the porphyrin core, a
process that leads to the loss of 2H+. Thienyl-porphyrins typically exhibit Q-bands in the 550800 nm region34.The emission data for the thienyl-porphyrin free bases, PP1-PP9, as well as the
Zn complexes in both toluene and DMF are listed in Tables 2-5, 2-6, 2-7 and 2-8. Both the free
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bases and the ZnPPs show a considerable red shift in emission bands relative to TPP and
ZnTPP respectively. When determining quantum yields of unknowns, the common practice is to
do this by comparing with a standard of known fluorescence yield. In our case, the standard used
is TPP ФF = 0.11)35 for the free bases, and ZnTPP ФF = 0.033)35 for ZnPPs. Compared to
TPP, thienyl-porphyrins have been shown to have lower quantum yields34. This can be attributed
to the presence of the heavy atom, sulfur, which quenches fluorescence. In our study, the same
trend was observed, not only for the free bases, but also for the Zn complexes. One observation
worth mentioning was the strikingly different quantum yields of PP9 in toluene and DMF. PP9
showed a quantum yield value of 0.164 in toluene, but a significantly lower value of 0.029 in
DMF. This correlates with literature findings which showed that in polar solvents, compounds
containing nido-carboranes exhibited low quantum yields. This has been attributed to presence of
hydrogen bonding, which enhances non-radioactive decay, and in turn reduced quantum yield36.
CuPPs showed a slightly blue shift in their absorption bands compared to both the ZnPPs and
the free bases. This could be attributed to the geometry of the Cu-porphyrin complexes. CuII has
a d9 electronic configuration. The unpaired electron in the dx2-y2 orbital pairs with the porphyrin
π,πӿ) excited states. As a result, these complexes do not exhibit the typical fluorescence as in the
case of Zn-porphyrin complexes, which has a closed shell. Rather, it undergoes strong
phosphorescence37.
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Figure 2-4: UV-Vis Absorption Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple),
PP5 (maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 6μ concentration in Toluene

Figure 2-5: Emission Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), PP5
(maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 1μ concentration in Toluene
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Table 2-5: Photophysical Data for PP1-PP9 and in Toluene
Compound

Absorbance
λmax(nm)

Q-bands λmax
(nm)

Emission
λmax (nm)

TPP
PP1
PP2
PP3
PP4
PP5
PP6a
PP7
PP9

418
421
423
423
425
425
428
427
429

505,539,580,640
510,547,588,646
516,554,593,649
511,547,588,644
514,559,589,647
514,553,590,646
516,558,595,654
516,556,594,653
558, 598,652

644,702(sh)
656, 709(sh)
667, 711(sh)
654, 711(sh)
664, 712(sh)
659, 711(sh)
674
673, 724(sh)
608, 655(sh)

Stoke’s
Shift
(nm)
225, 284
235, 288
244, 288
231, 288
239, 287
234, 286
246
246, 297
179, 226

Quantum
Yield (Ф)

Log Ԑ
(M-1cm-1)

0.11
0.030
0.009
0.043
0.015
0.027
0.015
0.014
0.164

5.62
5.64
5.65
5.06
5.58
5.64
5.63
5.45

Quantum
Yield (Ф)

Log Ԑ
(M-1 cm-1)

0.11
0.030
0.010
0.044
0.015
0.026
0.025
0.015
0.029

5.64
5.59
5.47
5.36
5.48
5.53
5.50
5.35

a -2 drops of TFA added to solution

Table 2-6: Photophysical Data for PP1-PP9 in DMF
Compound

Absorbance
λmax (nm)

Q-bands λmax
(nm)

Emission λmax
(nm)

TPP
PP1
PP2
PP3
PP4
PP5
PP6a
PP7
PP9

416
420
425
421
424
424
426
426
430

505,547
511,547,588,643
515,553,590,649
512,547,586,643
514,552,588,648
513,551,589,644
516,558,593,650
515,555,591,650
560, 598,645

646,708(sh)
652,707(sh)
670, 716(sh)
653, 712(sh)
663, 710(sh)
657, 709(sh)
672
671, 723(sh)
616, 661(sh)

a 2 drops of TFA added to solution
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Stoke’s
Shift
(nm)
230, 292
232, 287
245, 291
232, 291
239, 286
233, 285
246
245, 297
186, 231

Figure 2-6: UV-Vis Absorption Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple),
PP5 (maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 6μ concentration in DMF

Figure 2-7: Emission Spectra for PP1 (red), PP2 (green), PP3 (blue), PP4 (purple), PP5
(maroon), PP6 (pink), PP7 (yellow), and PP9 (brown) at 1μ concentration in DMF
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Figure 2-8: UV-Vis Absorption Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue),
ZnPP4 (purple), ZnPP5 (maroon), ZnPP6 (pink), and ZnPP7 (yellow) at 4μ concentration in
Toluene

Figure 2-9: Emission Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue), ZnPP4 (purple),

ZnPP5 (maroon), ZnPP6 (pink), and ZnPP7 (yellow) at at 1μ
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concentration in Toluene

Figure 2-10: UV-Vis Absorption Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue),
ZnPP4 (purple), ZnPP5 (maroon), ZnPP6 (pink), and ZnPP7 (yellow) at 4μ concentration in
DMF.

Figure 2-11: Emission Spectra for ZnPP1 (red), ZnPP2 (green), ZnPP3 (blue), ZnPP4
(purple), ZnPP5 (maroon), ZnPP6 (pink), and ZnPP7 yellow) at 6μ concentration in at 1μ
DMF
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Table 2-7: Photophysical Data for ZnPPs in Toluene
Compound

Absorbance
λmax (nm)

Q-bands
(nm)

Emission
λmax (nm)

Stoke’s shift
(nm)

Quantum
Yield (Ф)

Log Ԑ
(M-1 cm-1)

ZnPP1
ZnPP2
ZnPP3
ZnPP4
ZnPP5
ZnPP6
ZnPP7

428
426
426
428
430
432
431

551,596
548
547
551
552
554
557

613,657
604,648
602,649
608,656
609,653
621,657
618,658

185, 229
178, 222
176, 223
180, 228
179, 223
189, 225
187, 227

0.02
0.04
0.03
0.02
0.001
0.01
0.02

5.3
5.5
5.5
4.6
5.7
4.6
5.6

Table 2-8: Photophysical Data for ZnPPs in DMF

Compound

Absorbance
λmax (nm)

Q-bands
(nm)

Emission
λmax (nm)

Stoke’s shift
(nm)

Quantum
Yield (Ф)

Log Ԑ
(M-1 cm-1)

ZnPP1
ZnPP2
ZnPP3
ZnPP4
ZnPP5
ZnPP6
ZnPP7

428
428
429
430
431
433
433

560, 603
558, 599
557, 598
559
559, 603
560, 604
560, 604

618,664
609,658
609,659
616,664
615,661
624,662
622,664

190, 236
181, 230
180, 230
186, 234
184, 230
191, 229
189, 231

0.01
0.02
0.02
0.01
0.01
0.05
0.01

5.5
5.2
5.6
4.8
5.7
4.7
5.6
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Figure 2-12: UV-Vis Absorption Spectra for CuPP1 (red), CuPP2 (green), CuPP3 (blue),
CuPP4 (purple), CuPP5 (maroon), CuPP6 (pink), and CuPP7 yellow) at 4μ concentration in
Toluene.

Figure 2-13: UV-Vis Absorption for CuPP1 (red), CuPP2 (green), CuPP3 (blue), CuPP4
(purple), CuPP5 (maroon), CuPP6 (pink), and CuPP7 yellow) at 4μ concentration in D F.
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Table 2-9: Photophysical Data for CuPPs in Toluene
Compound

Absorbance λmax (nm)

Q-bands (nm)

Log Ԑ (M-1 cm-1)

CuPP1
CuPP2
CuPP3
CuPP4
CuPP5
CuPP6
CuPP7

423
418
419
421
422
426
424

537
533
532
534
537
538
537

5.2
5.5
5.5
4.5
5.0
4.6
5.0

Table 2-10: Photophysical Data for CuPPs in DMF

Compound

Absorbance λmax (nm)

Q-bands (nm)

Log Ԑ (M-1 cm-1)

CuPP1
CuPP2
CuPP3
CuPP4
CuPP5
CuPP6
CuPP7

422
416
418
420
422
425
424

537
533
533
535
538
539
540

5.5
5.6
5.9
4.7
4.9
4.8
5.2
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The UV-Vis data of PP12 and PP13 unfortunately showed aggregation of the porphyrins.
Addition of 2 drops of TFA to the solution containing the free bases did not change the outcome.
Different solvents, including Toluene, DMF, DCM, CHCl3 were used, but unfortunately there
still was aggregation as seen in figure 2-12 and 2-13.

Figure 2-14: UV-Vis Spectra of PP14 at 0.24M (red), 0.25M(green), and 0.26M (blue)M in
Toluene

Figure 2-15: UV-Vis spectrum of PP14 0.24M (red), 0.25M (green), and 0.26 (blue)M in
Toluene with 2 drops of TFA added to solution.
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2.7 Biological Studies
Porphyrins PP1-9 and ZnPP3 were all submitted for biological studies, which were performed
by Dr. Xiaoke Hu. The in vitro studies were carried out on the porphyrins using human
carcinoma HEp2 cells for the assays. With the exception of PP8, which recorded an IC50 value
of 380 μ , all the porphyrins showed no dark toxicities see Figure 2-12). When exposed to low
light dose (1 J/ cm), they all showed no phototoxicity( see Figure 2-13). At a concentration of
10μ , all porphyrins accumulated within the cells over time, with PP4 being taken up slightly
more than the other porphyrins (see Figure 2-14).

Figure 2-16: Dark Toxicities of porphyrins PP1(red), PP2(green), PP3(blue), PP4 (purple), PP5
(maroon), PP6 (pink), PP7 (yellow), PP9 (brown) and ZnPP3 (light blue) toward HEp2 cells
using Cell Titer Blue assay.

To determine the efficiency of tumor destruction, the subcellular localizations of porphyrins
PP1-9 and ZnPP3 in HEp2 cells were studied. The compounds were allowed to incubate
overnight at concentrations of 10μ , after which they were evaluated by fluorescence
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microscopy. The tracers used were BODIPY Ceramide (golgi), LysoSensor Green (lysosomes),
Mitotracker Green (mitochondria), and ER-tracker Green (ER).

Figure 2-17: Phototoxicities of porphyrins PP1 (red), PP2 (green), PP3 (blue), PP4 (purple),
PP5 (maroon), PP6 (pink), PP7 (yellow) and PP9 (brown) and ZnPP3 (light blue) toward HEp2
cells at 1 J/cm light dose using the Cell Titer Blue assay.

Figure 2-18: Time-dependent uptake of porphyrins PP1 (red), PP2 (green), PP3 (blue), PP4
(purple), PP5 (maroon), PP6 (pink), PP7 (yellow), PP9 (brown) and ZnPP3 (light blue) at
10μ by HEp2 cells.
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In all the micrographs, (a) shows the phase contrast (b) shows the overlay of phase contrast with
fluorescence of the compound, (c) shows fluorescence of ER-Tracker green, (d) shows the
fluorescence of ER-tracker green and the compound (e) shows the fluorescence of MitoTracker
Green (f) shows the overlay of the fluorescence of MitoTracker Green and the compound (g)
shows the fluorescence of LysoSensor Green (h) shows the overlay of the fluorescence of
LysoSensor Green and the compound (i) shows the fluorescence of BODIPY Ceramide, (j)
shows the overlay of the fluorescence of BODIPY Ceramide and the compound. To our pleasant
surprise, all compounds showed localization in mitochondria. This is a remarkable discovery,
because mitochondria is considered the “powerhouse” of the human cell. Therefore, destroying
of the cells will be more effective if the photosensitizer is located within the mitochondria.

PP1

PP2

Figure 2-19 Subcellular localization of PP1 and PP2 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of PP1 and PP2 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with PP1 and PP2. Scale bar: 10 μ .
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PP3

PP4

Figure 2-20: Subcellular localization of PP3 and PP4 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of PP3 and PP4 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with PP3 and PP4. Scale bar: 10 μ .

PP5

PP6

Figure 2-21: Subcellular localization of PP5 and PP6 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of PP5 and PP6 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with PP5 and PP6. Scale bar: 10 μ .
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PP7

PP9

Figure 2-22: Subcellular localization of PP7 and PP9 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of PP7 and PP9 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with PP7 and PP9. Scale bar: 10 μ .

Figure 2-23: Figure 3-18: Subcellular localization of ZnPP3 in HEp2 cells at 10μ for 24 h. a)
Phase contrast, (b) overlay of ZnPP3 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with ZnPP3. Scale bar: 10 μ .
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Table 2-11: A summary of the porphyrins PP1-9 and ZnPP3 localizations.
Compound

Localization

Partial Localization

PP1

Mitochondria, Golgi

Lysosome

PP2

Mitochondria

Golgi, Lysosome, ER

PP3

Mitochondria

Lysosome

PP4

Mitochondria

Golgi, Lysosome

PP5

Mitochondria, Golgi

Lysosome

PP6

Mitochondria, Golgi

Lysosome, ER

PP7

Mitochondria, Golgi

Lysosome, ER

PP9

Mitochondria, Golgi

Lysosome, ER

ZnPP3

Mitochondria

Lysosome, Golgi

2.8 Conclusions
The MacDonald [2+2] condensation was successfully used to synthesize a total of thirteen
thienyl-substituted porphyrins. In all cases, silica gel chromatography was used to purify the
products using mixtures of EtOAc/Hexane for elution. The photophysical data obtained showed
that the porphyrins were indeed potential candidates for PDT and BNCT. This was further
supported by the biological studies, which showed that all of them localized in various cell
organelles, including mitochondria, lysosome, golgi and the ER. Further work which entails
attempts to polymerize the porphyrins is currently underway.

2.9 Experimental
General Procedure
All reactions were monitored by thin layer chromatography (TLC) using 0.25mm silica gel plates
purchased from Sorbent technologies, with or without UV indicator (60F-254). All column
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chromatographies were run using silica gel, 32-63μm from Sorbent Technologies. 1H and

13

C

NMR spectra were obtained either on a DPX-250 or AV-400 Bruker spectrometer. Chemical
shifts δ) are given in ppm relative to CDCl3 (7.26ppm, 1H; 77.2ppm,

13

C), or acetone-d6

(2.05ppm, 1H; 54.0ppm 13C). MALDI-TOF mass spectra were obtained on a Bruker OmniFLEX
MALDI-TOF mass spectrometer. ESI-TOF was obtained on Agilent 6210. Decarborane and 1methyl-o-carborane were obtained from Katchem, Inc. (Czech Republic), while the other
reagents and solvents were obtained from either Sigma-Aldrich or Fischer Scientific, and were
used without further purification.
Cell Culture
All tissue culture media and reagents were obtained from Invitrogen. HEp2 cells were plated on
LabTek II two chamber coverslips. They were allowed to grow for a duration of 24-48h.
Compounds being investigated were then added at 10μ

and incubated overnight. This was then

followed by the addition of the tracers, which were added concurrently with the compound for
the remainder of the incubation period. The tracers used were: BODIPY Ceramide, ERTracker
Green, LysoSensor Green and MitoTracker Green. Distribution of the compound was determined
using a Zeiss AxioVert 200M inverted fluorescent microscope fitted with standard texas Red,
FITC, DAPI and Cy5LP filter sets.
Phototoxicity
The HEp2 cells were placed at 7500 per well in costar 96-well plate and allowed to grow
overnight. Compounds were diluted to 100μ

in medium, and then diluted to the final working

concentrations of 6.25μ . If D SO was required to dissolve the compound, a 1% D SO
concentration was maintained throughout the experiment and dilutions by replacing the growth
62

medium with medium plus 1% DMSO before making dilutions) The cells were then incubated
overnight (20-24h). The loading medium was then removed and the cells were fed medium
containing 50m

HEPES pH 7.4. The plate was placed on ice. It was then exposed to a 610nm

LP filtered light from a halogen lamp for 20 minutes 1 Jcm-2). IR radiation was filtered using a
10nm water layer contained in a petri dish placed on top of the 96 well plate. The medium was
removed and cells fed medium containing 20μL CellTiter Blue per 100μL medium and then
incubated for 4 hours. This was followed by conversion of the substrate by viable cells which
was measured by fluorescence.
Dark Toxicity
HEp2 cells were plated at 7500 cells per well in Costar 96-well plates and allowed to grow for
48h. Compounds were diluted to 100μ

in medium, and then diluted to 6.5μ . If D SO was

required to dissolve the compound, a 1% DMSO concentration was maintained throughout the
experiment and dilutions by replacing the growth medium with medium plus 1% DMSO before
making dilutions) The cells were incubated overnight (20-24h). Loading medium was then
removed and cells were fed medium containing 20μL CellTiter Blue per 100μL medium and
then incubated for 4h. This was followed by conversion of the substrate by viable cells which
was measured by fluorescence at 570/615nm.
Time Dependent Cellular Uptake
HEp2 cells were plated at 7500 per well on Costar 96-well dish and allowed to grow for 48h.
Compounds were diluted to a 20μ

stock in medium. Equal volume of the stock was added in

triplicate wells containing cells 100μL) to give a final concentration of 10μ . The cells were
exposed to the compounds for 1h, 2h, 4h, 8h and 24h. At the end of the incubation time, the
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medium was removed and the cells washed with 200μL of PBS. After removal of PBS, the cells
and compounds were then solubilized using 100μL of 0.25% Triton X-100 in PNS. To determine
the compound concentration, fluorescence emission was read using FLUOstar plate reader using
excitation/emission wavelengths appropriate for the compound under study. The cell numbers
were quantified using the CyQuant cell proliferation assay reagent.
Fluorescence Measurements
All experiments were performed at room temperature, in toluene and DMF. In some cases, a
drop of TFA was added to the dilute solutions to prevent aggregation. UV-Vis absorbance was
measured using a Perkin Elmer Lambda 35 UV-Vis Spectrometer. Fluorescence measurements
were taken on a Fluorolog®-HORIBA JOBINVYON, Model LFI-3751 Spectrofluorimeter.
Fluorescence quantum yields Фf) were calculated by using the following equation:

Where [F(sample)] and [F(standard)] are the integrated emission areas of the porphyrins and the
standard respectively. [A(standard)] and [A(sample)] are the optical densities of the standard and
the porphyrins, respectively, at the excitation wavelengths. Free base, TPP Фf = 0.11) was used
as the standard for free base porphyrins, and the Zn-complexed derivative, ZnTPP Фf = 0.033)
was used as the standard for ZnPPs.
General Procedure for Metal Insertion
Starting

material

was

dissolved

in

DCM/MeOH

(3:1)

and

excess

amount

of

Zn(OAc)2/Cu(OAc)2 added. For Zn-porphyrin complexes, the reaction mixture was stirred at
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room temperature for 24 hours. For Cu-porphyrin complexes, the reaction mixtures were stirred
at room temperature for 12 hours and then refluxed for 4 h. The resulting mixtures were dried
under vacuum and purified using column chromatography using DCM as eluent to afford the
final products.
Synthesis of DP-1
2-Thiophene carboxaldehyde (1.0g, 8.9 mmol) was added to freshly distilled pyrrole (25.7g,
382.7mmol) in a round bottom flask, under nitrogen. To this mixture was added TFA (0.1g, 0.89
mmol) and the mixture allowed to stir for 30 minutes at room temperature. The mixture was
poured in water (50 mL) and extracted with DCM (3 x 50mL). The organic layer was washed
with saturated NaHCO3 (3 x 50 mL), followed by water (3 x 50 mL). The organic layers were
dried over Na2SO4 and dried under vacuum. Crude product was purified by column
chromatography using 1:5 EtOAc:Hexane to obtain 1.3g of the title compound as 64% yield. 1H
NMR (CDCl3, 400 Hz) δ 7.83 2H, bs s), 7.11 1H, dd, J = 4 Hz, J= 1.2Hz), 6.86 (1H, m), 6.78
(1H, m), 6.58 (2H, d, J= 4Hz), 6.07 (2H, d, J= 4Hz), 5.94 (2H, br s), 5.62 (1H, S).

13

C NMR

(CDCl3, 100MHz) 145.8, 132.1, 126.9, 125.7, 124.7, 117.5, 108.6, 107.2, 39.2. ESI-TOF m/z
calcd for C13H10N2S 228.07, found 228.06 m.p. 117-118oC.
Synthesis of PP1
A solution of DP-1 (0.04g, 0.177mmol) and 2-thiophene-carboxaldehyde (0.0198g, 0.177mmol)
in 18 mL DCM was purged with argon for 15 minutes. BF3.OEt2 (0.0022g, 0.018mmol) in 18
mL DCM was also purged with argon for 15 minutes. The BF3.OEt2 solution was then added to
the solution containing the dipyrromethane and the aldehyde, and the mixture stirred at room
temperature for 2h. The reaction was monitored by TLC. After TLC confirmed no starting
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material present, DDQ(0.06g, 0.266mmol) was added to the reaction flask and the reaction
mixture stirred for 30 minutes. The reaction mixture was then filtered through a pad of silica gel,
and the filtrate dried under vacuum. The product was purified using column chromatography,
using 1:5 EtOAc:Hexane to afford 0.043g of the title compound as 56% yield.1H NMR (CDCl3,
250 Hz) δ 9.04 8H, s), 7.91 4H, d, J= 3.4Hz), 7.85 (4H, d, J=3.4Hz), 7.50 (4H, m). ZnPP1
obtained in 54% yield MALDI-TOF m/z calcd for C36N20N4S4Zn, 699.99, found 699.99. CuPP1
obtained in 71% yield MALDI-TOF m/z calcd for C36N20N4CuS4, 698.99, found 698.99.
Synthesis of PP2
A solution of DP-1 (0.04g, 0.177mmol) and benzaldehyde (0.019g, 0.177mmol) in 18 mL DCM
was purged with argon for 15 minutes. BF3.OEt2 (0.0022g, 0.018mmol) in 18 mL DCM was also
purged with argon for 15 minutes. The BF3.OEt2 solution was then added to the solution
containing the dipyrromethane and the aldehyde, and the mixture stirred at room temperature for
2h. The reaction was monitored by TLC. After TLC confirmed no starting material present,
DDQ(0.06g, 0.266mmol) was added to the reaction flask and the reaction mixture stirred for 30
minutes. The reaction mixture was then filtered through a pad of silica gel, and the filtrate dried
under vacuum. The product was purified using column chromatography, using 1:5
EtOAc:Hexane to afford 0.048 g of the title compound as 44% yield. 1H NMR (CDCl3, 250MHz
) δ 9.06 4H, d, J= 4Hz), 8.85 (4H, m), 8.23 (4H, m), 7.94 (2H, m), 7.87 (2H, m), 7.79 (6H, m),
7.52 (2H, m). 13C NMR (acetone-d6, 100MHz) 137.6, 134.3, 133.2, 131.5, 128.9, 128.1, 127.5,
126.5, 126.0, 125.2. ZnPP2 obtained in 98% yield. MALDI-TOF m/z calcd for.C40H24N4S2Zn,
688.07, found 688.06. CuPP2 obtained in 94% MALDI-TOF m/z calcd for C40H24CuN4S2,
687.07, found 687.089.
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Synthesis of PP3
A solution of DP-1 (0.02g, 0.088mmol) and 3,5-ditertbutyl benzaldehyde (0.019g, 0.088mmol)
in 9 mL DCM was purged with argon for 15 minutes. BF3.OEt2 (0.0012g, 0.0088mmol) in 9 mL
DCM was also purged with argon for 15 minutes. The BF3.OEt2 solution was then added to the
solution containing the dipyrromethane and the aldehyde, and the mixture stirred at room
temperature for 2h. The reaction was monitored by TLC. After TLC confirmed no starting
material present, DDQ(0.03g, 0.131mmol) was added to the reaction flask and the reaction
mixture stirred for 30 minutes. The reaction mixture was then filtered through a pad of silica gel,
and the filtrate dried under vacuum. The product was purified using column chromatography,
using 1:5 EtOAc:Hexane to afford 0.02 g of the title compound as 27% yield. 1H NMR (CDCl3,
400 Hz) δ 9.06 4H, m), 8.90 4H, m), 8.14 4H, m), 8.03 2H, s), 8.00 2H, d, J= 3Hz), 7.96
(2H, s), 7.56 (2H, m), 1.53 (36H, s). 13C NMR (acetone-d6, 100MHz) 149.0, 140.9, 133.9, 129.4,
128.1, 126.2, 121.5, 34.8, 31.1. HRMS(ESI) m/z calcd for C56H58N4S2, 851.4175, found
851.4193. ZnPP3 obtained in 53% yield. MALDI-TOF m/z calcd for C56H56N4S2Zn, 914.58,
found 914.33. CuPP3 obtained in 21% yield. MALDI-TOF m/z calcd for C56H56CuN4S2, 911.32,
found 911.21.
Synthesis of PP4
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.02g, 0.088mmol) and
3,5-methoxy benzaldehyde (0.015g, 0.088mmol), BF3.OEt2 (0.0012g, 0.0088mmol), and
DDQ(0.03g, 0.131mmol). The product was purified using column chromatography, using 1:5
EtOAc:Hexane to afford 0.013 g of the title compound as 20% yield.1H NMR (CDCl3, 400MHz)
δ 9.04 4H, m), 8.93 4H, m), 7.93 2H. d, J= 4Hz), 7.86 (2H, d, J= 4Hz), 7.51 (2H, m), 7.40
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(4H, s), 6.91 (2H, s), 3.97 (12H, s). HRMS(ESI) calcd for C44H34N4O4S2, 747.2094, found
747.2121. ZnPP4 obtained in 41% yield. MALDI-TOF m/z Calcd for C44H32N4O4S2Zn, 808.12,
found 808.17.
Synthesis of 5-bromothiophene-2-carbaldehyde (1)
Thiophene-2-carbaldehyde (1.0g, 8.92 mmol) and NaHCO3 (0.82g, 9.81 mmol) were dissolved
in dry CHCl3 (40 mL). The temperature was lowered to 0oC. The mixture was allowed to stir for
30 minutes. Bromine (1.43g, 8.92 mmol) was then added dropwise while stirring, and the
reaction allowed to warm to room temperature. The reaction mixture was stirred at this
temperature for 3 h. It was then poured into water. The organic layer was washed with saturated
NaHCO3 (2 x 20 mL), then water (3 x 20 mL) and the organic layers combined and dried over
Na2SO4. The product was then dried under vacuum, and purified by column chromatography
using 1:5 EtOAc:Hexane.1H NMR (CDCl3, 400MHz) 9.78 (1H, s), 7.53 (1H, d, J= 4Hz), 7.20
(1H, d, J= 4Hz).
Synthesis of DP-2
5-Bromothiophene-2-carbaldehyde (1) (1.0g, 5.23 mmol) was added to freshly distilled pyrrole
(15.1g, 224.89 mmol) in a round bottom flask, under nitrogen. To this mixture was added TFA
(0.06g, 0.523 mmol) and the mixture allowed to stir for 30 minutes at room temperature. The
mixture was poured in water (50 mL) and extracted with DCM (3 x 50mL). The organic layer
was washed with saturated NaHCO3 (3 x 50 mL), followed by water (3 x 50 mL). The organic
layers were dried over Na2SO4 and dried under vacuum. Crude product was purified by column
chromatography using 1:5 EtOAc:Hexane to obtain the title compound in 55 % yield. 1H NMR
(CDCl3, 400 Hz) δ 9.81 2H, br s), 6.94 1H, d, J= 4Hz), 6.70 (2H, d, J= 1.6Hz), 6.59 (1H, dd,
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J=2, J= 2 Hz), 6.00 (2H, m), 5.90 (2H, m), 5.67 (1H, s).

13

C NMR (CDCl3, 100MHz) 147.4,

129.5, 126.7, 125.8, 117.7, 108.6, 107.3, 39.5.
Synthesis of PP5
Procedure used was the same as that for PP1. Reagents used were, DP-2 (0.02g, 0.065mmol)
and 3,5-ditertbutyl benzaldehyde (0.014g, 0.065mmol), BF3.OEt2 (0.0001g, 0.0065mmol), and
DDQ(0.022g, 0.0975 mmol). The product was purified using column chromatography, using 1:5
EtOAc:Hexane to afford 0.013 g of the title compound as 20% yield. 1H NMR (CDCl3,
400 Hz) δ 9.10 6H, m), 8.89 4H, m), 8.07 4H, m), 7.72 3H, m), 7.67 3H, m), 7.49 4H, m),
1.53 (36H, s).

13

C NMR (CDCl3, 100MHz). 161.2, 161.4, 143.2, 137.6, 129.1, 128.3, 127.2,

125.4,105.3, 117.7, 31.1, 20.5. ESI-TOF calcd for C56H56Br2N4S2, 1009.01, found 1009.2329.
ZnPP5 obtained in 62% yield. MALDI-TOF m/z calcd for C56H54Br2N4S2Zn 1072.37, found
1072.138. CuPP5 obtained in 59% yield. MALDI-TOF m/z calcd for C56H54Br2CuN4S2 1069.14,
found 1069.12.
Synthesis of PP6
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.1g, 0.44mmol) and
methyl

5-formyl-1H-pyrrole-2-carboxylate

(0.067g,

0.44mmol),

BF3.OEt2

(0.0062g,

0.044mmol), and DDQ(0.15g, 0.655 mmol). The product was purified using column
chromatography, using 1:3 EtOAc:Hexane to afford 0.067 g of the title compound as 21% yield.
1

H NMR (CDCl3, 400 Hz) δ 9.07 6H, m), 7.94 2H, m), 7.88 2H, m), 7.53 4H, m), 7.29 4H,

s), 1.55 (6H, s). MALDI-TOF calcd for C40H28N6O4S2, 720.82, found 720.137. ZnPP6 obtained
in 98% yield. MALDI-TOF m/z calcd for C40H26N6O4S2Zn 784.18, found 784.077.
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Synthesis of PP7
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.1g, 0.44mmol) and
5-(4-methoxybenzoyl)-1H-pyrrole-2-carbaldehyde (0.089g, 0.44mmol), BF3.OEt2 (0.0062g,
0.044mmol), and DDQ(0.15g, 0.655 mmol). The product was purified using column
chromatography, using 1:3 EtOAc:Hexane to afford the title compound in 18% yield. 1H NMR
(acetone-d6, 400 Hz) δ 9.17 4H, br s), 9.10 4H, m), 8.11 4H, d, J= 5Hz), 8.04 (4H, m), 7.26
(4H, m), 7.43 (1H, m), 7.36 (1H, m), 7.05 (4H, m), 3.91 (6H, s). ZnPP7 obtained in 72% yield.
13

C NMR (acetone-d6, 100MHz) 151.1, 143.6, 133.4, 131.8, 131.7, 128.9, 128.1, 127.6, 126.0,

125.2, 114.9, 50.6, 20.5. MALDI-TOF m/z calcd for C52H34N6O4S2Zn 936.37, found 936.15.
Synthesis of Compound 2
To a solution of Cs[3,3‟-Co(1,2-C2B9H11)2] (1.0g, 2.2 mmol) in anhydrous 1,4-dioxane (100 mL)
was added BF3.OEt2 (2.49g, 17.52 mmol) and the reaction mixture heated at reflux under N2
atmosphere for 5h. The reaction mixture was allowed to cool temperature. It was then filtered,
and the filtrate dried under vacuum. The product was purified by column chromatography using
30% DCM/Hexane, followed by 100% DCM to obtain the title compound. Yield 72%. 1H NMR
data correlates to literature data.
Synthesis of PP8
BBr3 (0.2g, 0.81 mmol) was dissolved in DCM (0.5 mL) and the solution temperature lowered
to -20oC. Under N2 atmosphere, a solution of PP4 (0.02g, 0.027 mmol) in DCM (1 mL) was
added to the BBr3 solution slowly with stirring, over 15 minutes. The reaction mixture was then
allowed to warm up to room temperature, and allowed to stir for 24h. It was then poured into
water, followed by extraction with EtOAc. The organic layer was washed with brine, then
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saturated NaHCO3 solution. The organic layers were then dried over Na2SO4, filtered and dried
under vacuum to give the title product. Yield, 0.0162g, 87% 1H NMR (acetone-d6, 400 Hz) δ
9.01 (8H, br s), 8.67 (4H, m), 8.02 (4H, m), 7.54 (2H, m), 7.20 (4H, s), 6.80 (2H, t).
Synthesis of PP9
In a round bottom flask, PP8 (0.0162g, 0.023 mmol) and K2CO3 (0.025g, 0.184 mmol) were
dissolved in 15 mL acetone. The reaction mixture was allowed to stir at room temperature and
compound 2 (0.037g, 0.092 mmol) added in one portion. The reaction mixture was allowed to
stir at room temperature for 2h. This was followed by reflux for 24h, after which it was allowed
to cool to room temperature and a second portion of compound 2 (0.018g, 0.046 mmol) was
added. The reaction mixture was then refluxed for 24 h. After this period, it was cooled to room
temperature and a third portion of compound 2 (0.018, 0.046 mmol) added, followed by reflux
for 24 h. After cooling it to room temperature, the reaction mixture was dried under vacuum. The
product was purified by column chromatography using 1:1 EtOAc: Hexane to afford 60% yield.
1

H NMR (acetone-d6, 250 Hz) δ 8.98 6H, m), 7.94 2H, d, J= 4Hz), 7.86 (2H, d, J= 4Hz), 7.51

(4H, m), 7.13 (4H, m), 6.73 (2H, s), 5.13 (8H, m), 2.73 (8H, m), 2.21 (8H, m), 2.18 (8H, m), 1.80.5 (72H, br, BH).
Synthesis of Compound 3
3,5-Dimethylbromobenzene (0.1g, 0.54 mmol) was dissolved in dry CCl4 (7 mL). Under argon,
NBS (0.21g, 1.19 mmol) was added and benzoyl peroxide (0.02g, 0.07 mmol) added to the
reaction mixture in portions over 1 hr period. The final reaction mixture was refluxed with
stirring for 16 h. It was then allowed to cool to room temperature, after which it was filtered and
the filtrate washed with saturated NaHCO3 and once with water. The organic layer was dried
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over Na2SO4 and dried under vacuum. The resulting residue was purified by column
chromatography using DCM/PET ether 1/9 as eluant. 1H NMR (CDCl3, 400MHz) 7.62 (2H, d,
J= 4Hz), 7.49 (1H, s), 4.55 (4H, s).
Synthesis of Compound 4
1-Methyl-o-carborane (0.202g, 1.276 mmol) was dissolved in dry THF (13 mL) and temperature
kept between -5 and 0oC. n-BuLi (2.5M/Hexane) (0.49ml, 1.22 mmol) was added dropwise to
the solution under argon. The mixture was stirred at this temperature range for 1.5h, and
temperature lowered between between -15oC and - 20oC. A solution of LiI (0.02g, 0.18 mmol) in
dry THF (1.7 mL) and 1-bromo-3,5-bis(bromomethyl)benzene (0.2g, 0.58 mmol) in THF (3
mL) were added to the reaction mixture, and the final mixture allowed to warm to room
temperature and stirred for 16h at this temperature. The reaction was quenched with water, and
the resulting mixture extracted with diethyl ether (3 x 10 mL). The organic layers were combined
and washed with water, and brine. The organic layer was then dried over Na2SO4, and dried
under vacuum. Product was purified using column chromatography using DCM/PET ether 1/4.
1

H NMR (CDCl3, 400 Hz) δ 7.48 2H, s), 7.32 1H, s), 4.41 4H, s), 3.42 6H, s), 2.9-1.5(20H,

br, BH).
Synthesis of Compound 5
Dicarboranylbromobenzene (0.286g, 0.57 mmol) was dissolved in THF (6 mL) and the solution
put under argon. It was then cooled to -78oC and nBuLi (2.5M/Hexane) (0.26 ml, 0.64 mmol)
was added dropwise via syringe. After stirring the reaction mixture for 30 minutes at this
temperature, dry DMF (0.21g, 2.85 mmol) was slowly added. The resulting mixture was stirred
at -78oC for 30 minutes and then warmed up to 0oC and stirred for 1h at this temperature. A 5%
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aqueous HCl solution was added until the pH of the reaction mixture was between 2 and 3. The
final mixture was stirred at room temperature for 15 minutes. The aqueous layer was extracted
with diethyl ether, and the organic fraction dried over anhydrous MgSO4 and the solvent
evaporated under vacuum. The product was purified by column chromatography using
DCM/PET ether 2/3 to obtain 50% of title compound. 1H NMR (CDCl3, 400 Hz) δ 9.98 1H,
s), 7.62 (2H, d, J = 1.5Hz), 7.28 (1H, d, J = 1.5Hz), 3.52 (4H, s), 2.18 (6H, s), 1.3-3.2 (20H, br)
Synthesis of PP10
Procedure used was the same as that for PP1. Reagents used were, DP-1 (0.02g, 0.088mmol),
compound 6 (0.04g, 0.088mmol), BF3.OEt2 (0.0012g, 0.0088mmol), and DDQ (0.003g,
0.0132mmol). Product was purified using silica gel chromatography using 1:3 EtOAc/Hexane to
give 0.007g, 6% of the title compound. 1H NMR (CDCl3, 400 Hz) δ 9.00 4H, m), 8.93 4H,
m), 8.07 (4H, m), 8.02 (2H, s), 7.98 (2H, m), 7.96 (2H, s), 7.54 (2H, m), 3.92 (s, 8H), 2.33 (s,
12H), 1.2-3.3 (br, 40H).
Synthesis of Compound 7
5-Bromothiophene-2-carbaldehyde (1.674g, 8.765 mmol), PdCl2(PPh3)2 (0.154g, 0.219 mmol),
and CuI(0.0834g, 0.438 mmol) were dissolved in THF (30 mL). TMSA (0.947g, 9.64 mmol) was
added to the reaction mixture under argon and Et3N (36 mL) added to the reaction mixture. The
reaction was allowed to stir at room temperature for 24 h. The reaction mixture was then poured
into water, and extracted with EtOAc. Product was purified using 1:5 EtOAc/Hexane 1HNMR
(CDCl3, 400 Hz) δ 9.85 1H, s), 7.62 1H, d, J= 4), 7.28 (1H, d, J=4), 0.27 (9H, s).
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Synthesis of DP-4
5-((trimethylsilyl)ethynyl)thiophene-2-carbaldehyde

(0.3g, 1.44mmol) was added to freshly

distilled pyrrole (1.93g 28.80 mmol) in a round bottom flask, under nitrogen. To this mixture
was added TFA (0.033g, 0.288 mmol) and the mixture allowed to stir for 30 minutes at room
temperature. The mixture was poured in water (5 mL) and extracted with DCM (3 x 5mL). The
organic layer was washed with saturated NaHCO3 (3 x 5 mL), followed by water (3 x 5 mL). The
organic layers were dried over Na2SO4 and dried under vacuum. Crude product was purified by
column chromatography using 1:3 EtOAc:Hexane to obtain the title compound in 54 % yield. 1H
NMR (CDCl3) δ 7.97 2H, br s), 7.09 1H, d, J=4Hz), 6.73 (3H, m), 6.17 (2H, d, J= 2.5Hz), 6.05
(2H, s), 5.68 (1H, s), 0.23 (9H, s).
Synthesis of DP-3
Trimethylsilane protecting group was removed by reacting DP-4 (0.03g, 0.092 mmol) with
K2CO3 (0.038g, 0.276mmol) dissolved in a Hexane/MeOH mixture (8:2) (5 mL) at room
temperature for 2h. The reaction was quenched by adding water. This was extracted with Et2O,
and the organic layer dried over Na2SO4 and dried under vacuum. The title compound was
obtained in 73% yield. 1H NMR (CDCl3, 400 Hz) δ 8.01 2H, br s), 7.13 1H, d, J= 4), 6.76
(1H. d, J= 4), 6.72 (2H, d, J= 1.5 Hz), 6.18 (2H, dd, J= 4Hz), 6.06 (2H, s), 5.70 (1H, s), 3.3 (1H,
s). ESI-TOF calcd for C15H12N2S, 252.33 found, 253.08.
Synthesis of DP-5
Decarborane (0.15g, 0.60 mmol), DP-3 (0.15g, 1.20 mmol), dry CH3CN (1.5 mL) and dry
toluene (4.5 mL) was mixed in a round bottom flask. The reaction was stirred under N 2 at 80oC
for 24h. After it was cooled to room temperature, MeOH (3.0 mL) was added to the reaction
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flask and stirred for 30 minutes. The reaction mixture was dried under vacuum, and the product
purified by column chromatography using 20% DCM/Hexane as eluent, to yield 34% of the title
product. 1H NMR 7.93 (2H, br s), 7.63 (1H, s), 7.47 (1H, s), 6.93 (2H, m), 6.65 (3H, m), 6.07
(1H, d, J= 4), 5.94 (1H, s), 1.8-0.5 (10H, br, BH).
Synthesis of PP11
Procedure used was the same as that for PP1. Reagents used were, DP-5 (0.006g, 0.016mmol)
and 3,5-ditertbutyl benzaldehyde (0.004g, 0.0.016mmol), BF3.OEt2 (0.00023g, 0.0016 mmol),
and DDQ(0.005g, 0.024 mmol). The product was purified using column chromatography, using
1:5 EtOAc:Hexane to afford the title compound in 6% yield. 1H NMR (CDCl3, 400 Hz) δ 9.23
(4H, m), 8.97 (4H, m), 7.91 (2H, d, J= 4Hz), 7.47 (2H, m), 7.87 (2H, d, J= 4Hz), 7.34 (4H, m),
1.89 (s, 36H), 1.3-3-2 (br, 20H). MALDI-TOF m/z calcd for C60H78B20N4S2, 1134.76, found
1134.97.
Synthesis of Compound 9
[2,2'-Bithiophene]-5-carbaldehyde (2.0g, 10.29 mmol) was dissolved in CHCl3 (20 mL). The
temperature was lowered to 0oC. Bromine (1.65g, 10.29 mmol) was added dropwise to the
reaction flask, and the reaction mixture allowed to warm to room temperature. It was allowed to
stir at this temperature for 2h. The reaction mixture was poured into 20 mL water. The organic
layer was then washed with saturated NaHCO3 and dried over Na2SO4. The product was purified
by column chromatography using 1:3 EtOAc/Hexane to obtain 2.5g of the target compound. 1H
NMR (CDCl3, 250MHz) 9.86 (1H, s), 7.66 (1H, d, J= 4), 7.19 (1H, d, J= 4), 7.11 (1H, d, J= 4),
7.03 (1H, d, J= 4).
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Synthesis of Compound 13
5'-Bromo-[2,2'-bithiophene]-5-carbaldehyde (1.0g, 3.65 mmol), PdCl2(PPh3)2 (0.064g, 0.091
mmol), and CuI(0.035g, 0.183 mmol) were dissolved in THF (40 mL). TMSA (0.39g, 4.0 mmol)
was added to the reaction mixture under argon and Et3N (40 mL) added to the reaction mixture.
The reaction was allowed to stir at room temperature for 24 h. The reaction mixture was then
poured into water, and extracted with EtOAc. Product was purified with column
chraomatography using 1:3 EtOAc/Hexane. 1H NMR (CDCl3, 400MHz) 1H NMR (CDCl3,
400 Hz) δ 9.87 1H, s), 7.67 1H, d, J= 4Hz), 7.24 (1H, d, J= 4), 7.20 (1H, d, J=4), 7.17 (1H, d,
J= 4), 0.26 (9H, s).
Synthesis of DP-6
5'-((Trimethylsilyl)ethynyl)-[2,2'-bithiophene]-5-carbaldehyde (0.124g, 0.43mmol) was added
to freshly distilled pyrrole (0.57g, 8.55 mmol) in a round bottom flask, under nitrogen. To this
mixture was added TFA (0.0097g, 0.086 mmol) and the mixture allowed to stir for 30 minutes at
room temperature. The mixture was poured in water (2 mL) and extracted with DCM (3 x 2mL).
The organic layer was washed with saturated NaHCO3 (3 x 2 mL), followed by water (3 x 2 mL).
The organic layers were dried over Na2SO4 and dried under vacuum. Crude product was purified
by column chromatography using 1:3 EtOAc:Hexane to obtain the title compound. 1H NMR
(CDCl3, 400MHz) 8.04 (2H, br s), 7.18 (1H, m), 7.08 (1H, m), 6.94 (1H, m), 6.84 (1H, d, J= 4),
6.80 (1H, d, J= 4), 6.73 (2H, s), 6.27 (1H, d, J= 1.8Hz), 6.19 (2H, d, J= 3Hz), 5.71(1H, s), 0.25
(9H, s). ESI-TOF calcd for C22H22N2S2Si, 406.10, found 406.09.
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Synthesis of DP-7
Trimethylsilane protecting group was removed by reacting DP-6 (0.12g, 0.30 mmol) with
K2CO3 (0.12g, 0.89mmol)

dissolved in a Hexane/MeOH mixture (8:2) (20 mL) at room

temperature for 2h. The reaction was quenched by adding water. This was extracted with Et 2O,
and the organic layer dried over Na2SO4 and dried under vacuum. 1H NMR (CDCl3, 400MHz) δ
8.06 (2H, br s), 7.19 (1H, d, J= 4), 7.09 (1H, m), 6.99 (2H, m), 6.73 (3H, m), 6.19 (2H, d, J=
2.8Hz), 6.09 (1H, s), 5.72 (1H, s), 3.34 (1H, s). ESI-TOF calcd for C19H14N2S2, 334.06, found
334.05.
Synthesis of DP-8
Decarborane (0.10g, 0.30 mmol), DP-7 (0.07g, 0.60 mmol), dry CH3CN (1.0 mL) and dry
toluene (3.0 mL) was mixed in a round bottom flask. The reaction was stirred under N 2 at 80oC
for 24h. After it was cooled to room temperature, MeOH (2.0 mL) was added to the reaction
flask and stirred for 30 minutes. The reaction mixture was dried under vacuum, and the product
purified by column chromatography using 20% DCM/Hexane as eluent
Synthesis of PP12
Procedure used was the same as that for PP1. Reagents used were, DP-8 (0.010g, 0.022mmol)
and 3,5-ditertbutyl benzaldehyde (0.005g, 0.022mmol), BF3.OEt2 (0.0003g, 0.0022mmol), and
DDQ(0.008g, 0.033mmol). The product was purified using column chromatography, using 1:3
EtOAc:Hexane to afford 0.002g of the title compound as 8% yield. 7.91 (4H, br s), 7.57 (2H, d,
J=4Hz), 7.52 (4H, m), 7.29 (4H, m), 7.17 (4H, m), 6.60 (4H, m), 1.94 (36H, s), 1.4-3-5 (br,
20H).
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Synthesis of DP-9
2,2‟-Bithiophene)-5-carboxaldehyde (1.0g, 5.15 mmol) dissolved in minimal DCM was added
to freshly distilled pyrrole (6.91g, 102.95 mmol) in a round bottom flask, under nitrogen. To this
mixture was added TFA (0.04g, 0.515 mmol) and the mixture allowed to stir for 30 minutes at
room temperature. The mixture was poured in water and washed with saturated NaHCO3. The
organic layers were dried over Na2SO4 and dried under vacuum. Crude product was purified by
column chromatography using 1:4 EtOAc:Hexane. 1H NMR (CDCl3, 250 Hz) δ 7.95 2H, br s),
7.26 (1H, d, J= 4), 7.24 (1H, d, J= 4), 7.20 (2H, m), 6.73 (2H, m), 6.26 (2H, m), 6.04 (2H, s),
5.70 (1H, s).
Synthesis of PP13
Procedure used was the same as that for PP1. Reagents used were, DP-9 (0.15g, 0.48mmol) and
3,5-ditertbutyl benzaldehyde (0.105g, 0.48 mmol), BF3.OEt2 (0.0069g, 0.048 mmol), and
DDQ(0.165g, 0.727 mmol). The product was purified using column chromatography, using 1:5
EtOAc:Hexane to afford the title compound in 18% yield. 1H NMR (CDCl3, 400 Hz) δ 7.99
(4H, br s), 7.69 (2H, d, J= 4Hz), 7.62 (2H, d, J=4Hz), 7.54 (4H, m), 7.33 (4H, m), 7.22 (4H, m),
6.73 (4H, m), 1.96 (36H, s). ESI-TOF calcd for C64H62N4S4, 1015.46, found 1015.84. ZnPP13
MALDI-TOF m/z calcd for C64H60N4S4Zn 1078.83, found 1078.085.
Synthesis of PP14
Procedure used was the same as that for PP1. Reagents used were, DP-9 (0.097g, 0.315mmol)
and 3,5-dimethoxy benzaldehyde (0.052g, 0.315 mmol), BF3.OEt2 (0.0045g, 0.0315 mmol), and
DDQ(0.143g, 0.629 mmol). The product was purified using column chromatography, using 1:5
EtOAc:Hexane to afford the title compound in 21% yield. 1H NMR (CDCl3, 400 Hz) δ 7.89
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(4H, br s), 7.52 (8H, m), 7.25 (8H, m), 6.09 (4H, m), 2.01 (12H, s). ESI-TOF calc for
C52H38N4O4S4, 911.14, found 911.48. ZnPP14 MALDI-TOF m/z calcd for C52H36N4O4S4Zn
972.09, found 972.069. CuPP14 MALDI-TOF m/z calcd for C52H36CuN4O4S4, 972.67, found
973.22.
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CHAPTER 3: CARBORANYL FUNCTIONALIZED THIOPHENES FOR
ELECTROPOLYMERIZATION AND BNCT
3.1 Introduction
Since prehistoric time, polymers have been used by Man in the form of skin, wood, bone, and
fibers. Today, synthetic polymers represent the most widely used material in our day to day life.
The development of polymeric science dates back to the 20th century, and since then, a lot of
research has been carried out in this field. It is important to note that polymers were essentially
designed to be insulators. We have materials such as plastics, rubber tubings, live wire plastic
coatings, and anti-rusting materials. The list goes on and on. This was the case until 1976, when
American scientists Heeger and MacDiarmid and their Japanese colleague Shirakawa discovered
that when doped with iodine, polyacetylene developed metal-like properties with an increase in
conductivity; this marked the beginning of modern development of conducting polymers1. Since
then, many other conducting polymers have been synthesized including polypyrrole2,
polyaniline3, poly(isothianaphthene)4 and poly(phenylenevinylene)5(see examples in Figure 31).

Figure 3-1: Structures of poly(phenylenevinylene) 1 and polyaniline 2

In our research, we are interested in one group of conducting polymers, heterocyclic conjugated
polymers. These polymers can be viewed as sp2px chains whereby the structure similar to that of
cis-(CH)x is stabilized by a heteroatom6 (Figure 3-2). Since their discovery, heterocyclic
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conjugated polymers have found a wide range of applications including in sensors7, electronics8,
energy storage9 and catalysis10.

Figure 3-2: Structure of cis-(CH)x and heterocyclic conjugated polymers stabilized by a
heteratom

3.2 Polythiophene Synthesis
Polythiophenes in particular have attracted a lot of interest in the research world and they have
fast become the most frequently used π-conjugated materials. The main reason for this is that
thiophenes can be easily functionalized to make a wide range of compounds. They can also be
used as building blocks to make π-conjugated systems using transition metal-catalyzed crosscoupling reactions that are well developed. Another reason is that they have unique redox,
optical and electronic properties, as well as the ability to self-assemble on solid surfaces11. There
are two main routes by which polythiophenes (PTs) can be synthesized, i.e. the chemical route
and the electrochemical route. Since their first synthesis in the 1980‟s, many PTs have been
prepared by chemical synthesis. There has been a lot of interest in this field especially with the
marked improvements in solubility of the PTs. The major drawback, however, is that polymers
produced by this method contain significant regiochemical defects. This in turn leads to a loss of
effective conjugation, and hence reduced conductivity levels. McCullough et al.12 and Rieke et
al.13 have both designed syntheses that help overcome this problem (see Scheme 3-1). As a
result, the polymers obtained have shown improved conductivity levels6, 14.
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Scheme 3-1: Two synthetic routes for preparing polythiophenes14
The second type of polymer synthesis, electropolymerization, also helps overcome this problem
of regio-irregularity. In 1979, it was shown that polypyrrole could be produced by
electropolymerization of pyrrole15. This process has since been extended to other aromatic
compounds, including, polyaniline16, furan17, indole18, benzene19, and thiophene18. Synthesis of
polythiophenes via electropolymerization has proved to be a challenge due to the so called
“polythiophene paradox”. This phenomenon refers to the overoxidation of polythiophenes
whereby it competes with polymerization and oxidation of the monomer leading to the physical
and chemical degradation of the polymer20. The mechanism of electrochemical formation of
conducting polymers is characterized by the deposition of charged species produced by oxidation
of the neutral monomer at the anode surface (Scheme 3-2).
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Scheme 3-2: Mechanism of electrochemical formation of conducting polymers6

The control of structure and properties of PTs has been pursued through the modification of the
monomer structure. This can be achieved by the use of oligothiophenes as the monomeric unit 6.
The motivation behind this approach is based on two major reasons. First, the lower oxidation
potentials of oligothiophenes21 facilitate electropolymerization under mild conditions, i.e. at less
positive potentials22. This will in turn limit the occurrence of side reactions or overoxidation of
the deposited polymer. Secondly, using oligomers might reduce the α-β‟ defects in the polymer,
since the oligomer is α-α‟ linked in the starting molecule23. The drawback with this method is
that with an increase in conjugation in the starting monomer, there is a decrease in the reactivity
of the corresponding cation radical. This inhibits the electropolymerization process, which
affords low molecular weight polymers, and low conductivities24. However, even with these
limits in mind, the use of oligomers provides the advantage of designing sophisticated structures
which can be used to synthesize polymers with unique properties.
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The structure of a monomer can be modified by functionalization of the monomers with electronwithdrawing groups. For example, it has been shown that introduction of an electron
withdrawing group at the 3- and/or 4- position of a thiophene significantly decreases the
polymerization potential and in turn increasing the photovoltaic polymer performance20a, 23b, 25.
Functionalization of monomers with organoborane groups in particular is attractive due to their
electron deficient nature20b,22. However, despite the remarkable properties associated with
electron-deficient boron, organometallic polymers containing boron, have not been well
established. This is due in part to the hydrolytic and oxidative sensitivity of many boroncontaining molecules, thereby making the incorporation of boron into polymers synthetically
difficult. Recent studies however show that not only can boron-containing polymers be obtained
in high molecular weight, but also the polymers obtained are remarkably stable over long periods
of time. This can be attributed to the development of new synthetic approaches to the synthesis
of these polymers, as well as new methods of stabilization of the polymers. Organoborane
polymers can be classified into three main categories, depending on the chemical structure of the
organoborane

polymer26;

main-chain

functionalized

conjugated

polymers,

side-chain

functionalized conjugated polymers and side-chain functionalized polyolefins, as shown in
Figure 3-3.

Figure 3-3: Three main categories of organoborane polymers26.
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One of the most recent advancement in the synthesis of polymeric organoboranes is the
introduction of carboranes into the polymeric system. Carboranes refer to boron clusters which
can either be neutral or anionic (see Figure 3-4). As a result of their three dimensional aromatic
character, carboranes in both neutral and anionic forms have unique properties which include,
low nucleophilicity, high hydrophobic character, as well as high chemical, thermal and optical
stability27. Studies have shown that treatment of the closo carborane with a base readily removes
a boron to form the nido ion28. Complexation of these open carborane cages with metals such as
Ni, Co and Fe, leads to sandwich-type complexes that are highly stable. The overall charge of
these complexes will vary from neutral to charged with the overall charge of -1 or -2, depending
on the oxidation of the metal ion28c. These complexes have found practical uses in various fields,
including in Boron Neutron Capture Therapy (BNCT) of tumors

29

, molecular recognition30, in

construction of molecular rotors31 and in solvent extraction of radionuclides32.

Figure 3-4: Structures of carborane cages.

We are therefore interested in the preparation of carborane substituted oligothiophenes. These
compounds incorporate the desirable properties of oligothiophenes as well as those of
carboranes. We expect the resulting compounds to have remarkable photophysical properties and
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high stability compared to oligothiophenes without the carboranes groups. We will carry out the
polymerization (chemical and electrochemical) of the cobaltabis(dicarbollide) oligothiophenes
and study the physical properties of the resulting polymers. The major challenge in the
polymerization of the oligothiophenes is the “polythiophene paradox” as mentioned earlier. We
hope to overcome this problem with the incorporation of the electron deficient carborane into the
monomeric oligothiophenes.
3.3 Results and Discussion
Synthesis of the oligothiophenes was started by Dr. Erhong Hao in our group, and we used
procedures that he developed to reproduce the compounds and carry out the photophysical
studies. We began by synthesis of 3 from 2-ethynylthiophene and decaborane in 56% yield as
shown in Scheme 3-3. Treatment of the carborane with TBAF gave 4 in quantitative yield as a
NBu4 salt. Compound 5 was then synthesized by reacting 4 with tBuOK and Co(OAc)2 in DME.
Compound 5 was obtained after air oxidation in 70% overall yield.

Scheme 3-3: Synthesis of thiophene-disubstituted cobaltabis(dicarbollide) 5

The UV-Vis and fluorescence emissions of 3 and 4 were studied in DCM, MeOH and DMF.
Compound 4 showed an absorption maximum that is higher than 3 in all solvents. In DCM, for
example, 4 showed a maximum absorption peak at 271 nm, while 3 showed a maximum
absorption at 250 nm as shown in Figure 3-5. Next we prepared the bithiophene analogue. We
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started with 5-bromo-2,2'-bithiophene, which was subjected to Sonogashira coupling using
trimethylsilyl acetylene, followed by deprotection of the trimethylsilane using K2CO3 to afford
80% of 7 after flash chromatography as shown in Scheme 3-4. Deprotection using K2CO3 was
preferred over using 0.1M TBAF, which yielded a product that was difficult to purify, and
consequently led to low yields. Compound 7 was then reacted with B10H14 to yield 70% of 8.
This was then followed by degradation using TBAF to give 9 in quantitative yields. Reaction of
9 with tBuOK and Co(OAc)2 followed by air oxidation afforded 58% of compound 10.

Figure 3-5: UV-vis absorption spectra of 3 (red) and 4 (green) in DCM at 25oC

The UV-vis of 8 and 9 were studied in DCM, MeOH and DMF at room temperature. Just like
compounds 3 and 4, compound 9 showed a maximum absorption peak at a longer wavelength at
329 nm, compared to the maximum absorption peak at 316 nm for compound 8 in DCM as
shown in Figure 3-6.
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Figure 3-6: Uv-vis apsorption spectra of 8 (red) and 9 (green) in DCM at 25oC

Scheme 3-4: Synthesis of bithiophene-disubstituted Co- and Ni-bis(dicarbollide) 10 and 11
92

Scheme 3-5: Synthesis of 5-ethynyl-2,2':5',2''-terthiophene, 14.

Our next step was the synthesis of the terthiophene analogue. We started the synthesis by
brominating 2,2':5',2''-terthiophene using NBS to afford 12 in 76% yield as shown in Scheme 35. This was followed by a Sonogashira coupling reaction with 12 and TMSA. Deprotection of
the trimethylsilane group was carried out using K2CO3 to afford 67% yield of compound 14.
Reaction of 14 with B10H14 afforded 15 in 50% yield. Treatment with base afforded 16 in
quantitative yield. Finally, the reaction of 16 with tBuOK and Co(OAc)2 and Ni(OAc)2 afforded
17 and 18 in 60 and 43% yield respectively.

Scheme 3-6: Synthesis of terthiophene-disubstituted Co- and Ni-bis(dicarbollide) 17 and 18.
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The UV-vis of 15 and 16 studied in DCM showed that compound 16 had a maximum absorption
peak at a longer wavelength than compound 15. Compound 16 has a maximum absorption peak
at 369 nm, while 15 has a maximum absorption peak at 360 nm in DCM as shown in Figure (37).

Figure 3-7: UV-vis spectra for 15 (red) and 16 (green) in DCM at 25oC

An attempt to synthesize the quaterthiophene-disubstituted metallabisdicarbollides proved to be
futile (see Scheme 3-7). This was as a result of the highly insoluble quaterthiophene compounds
in regular organic solvents.

Scheme 3-7: Synthesis of ([2,2':5',2'':5'',2'''-quaterthiophen]-5-ylethynyl)trimethylsilane, 20
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3.4 Electropolymerization of the Cobalt(III)bisdicarbollide Complexes
Electropolymerization of the cobalt(III)bisdicarbollide complexes was carried out by our
collaborator, Dr. Bruno Fabre from Université de Rennes 1, France. Both the bis(bithienyl) and
bis(terthienyl)

cobalt(III)bisdicarbollide

metallopolymers.

The

bis(thiophene)

complexes,

10

and

cobalt(III)bisdicarbollide

17,
5

yielded
however,

conducting
did

not

electropolymerize. This can be attributed to the fact that with an increase in the length of the
oligothiophene substituents, there is a decrease in the oxidative potential. This is supported by
DFT calculations which indicate that as the length of the oligothiophene substituents increase,
there is a drastic decrease in the metallic and dicarbollide cage carbon atom contributions, so that
the HOMOs can be considered almost purely oligothiophene based (see Figure 3-8).

Figure 3-8: HOMOs and LUMOs of 5, 10 and 17 from DFT calculations28c
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To help understand the properties of the polymers further, a UV-Vis spectroscopic analysis was
performed on poly(10) and poly(17). The UV-Vis spectrum was carried out in DCM. For
compounds 5, 10 and 17, the bands that appeared between 260-280 nm and 460-500 nm can be
attributed to the cobaltabisdicarbillide center, with the weaker one being due to d-d transition in
the Co metal. 5, 10 and 17 had λmax values of 250, 325 and 375 nm respectively. The polymers
poly(10) and poly(17) showed absorption maximum at 410 and 448 nm respectively, which was
expected since poly(17) assimilates the more conjugated sexithiophene compared to poly(10)
which assimilates the quaterthiophene components (see Figure 3-9).
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Figure 3-9: Solid-state UV-vis spectra of (A) poly(10) and (B) poly(17) in their doped (solid
line) and reduced (dotted line) states28c.

Studies on the surface morphologies of the polymers were carried out by Dr. Zorabel M. LeJeune
and Dr. Jayne Garno in the Department of Chemistry at LSU. Samples of the doped and undoped
films of the polymers were characterized using tapping-mode AFM. It was concluded that the
undoped samples of poly(10) and poly(17) were more compressed and less rugged, compared to
the doped samples (see Figure 3-10). Furthermore, a study of the polymer conductivity was
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I

II

Figure 3-10: (A,C,E) Tapping-mode AFM topographs and (B,D,F) corresponding phase
topographs of neutral undoped (I) and p-doped (II) (A,B) poly(5), (C,D) poly(10) and (E,F)
poly(17). Scan size for all topographs: 5 x 5μm2 28c

carried out using conductive probe AFM. This was done by measuring the current (I) flowing
through the polymer/gold surface junction against an applied voltage (V). From the profiles, it
can be seen that the more conjugated poly(17) is more conducting than poly(10) as shown in
Figure 3-11.
3.5 Photophysical Studies of Oligothiophenes
The effect of carboranes on the photophysical properties of the oligothiophenes was studied by
comparing the absorption and emission of the carborane containing oligothiophenes with those
of free oligothiophenes. We also compared the quantum yield of the different oligothiophenes as
well as the solvent effects on quantum yields.
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Figure 3-11: Current-voltage curves (A) and corresponding semilog plots (B) for as-grown
doped poly(5), poly(10) and poly(17), acquired under ambient conditions28c.

Table 3-1: Photophysical Data of oligothiophenes in DCM

Compound

Absorbance
λmax (nm)

Emission
λmax (nm)

Stoke’s Shift
(nm)

Quantum
Yield ФF

Log Ԑ (M-1
cm-1)

21

-

-

-

-

-

3

250

352

102

0.006

5.0

4

271

342

71

0.07

3.8

22

303

362

59

0.018

4.0

8

317

394, 463

77, 146

0.161

3.8

9

328

399, 482

71, 154

0.254

4.3

23

354

407,426

53, 72

0.210

4.1

15

360

434

74

0.416

4.5

16

369

437

68

0.569

5.2
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Figure 3-12: Structures of oligothiophenes studied

Table 3-2: Photophysical data of oligothiophenes in MeOH
Compound

Absorbance
λmax (nm)

Emission
λmax (nm)

Stoke’s Shift
(nm)

Quantum
Yield ФF

Log Ԑ (M1
cm -1)

21

-

-

-

-

-

3

238

362

124

4.6 x 10-5

3.8

4

268

322

54

4.6 x 10-3

3.8

22

301

370

69

0.031

4.2

8

316

427

111

0.068

3.8

9

354

403, 423

49, 69

0.069

4.3

23

351

403, 424

52, 73

0.063

4.1

15

371

461

90

0.086

4.3

16

355

404, 424

49,69

0.085

4.9
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Table 3-3: Photophysical data of oligothiophenes in DMF
Compound

Absorbance
λmax (nm)

Emission
λmax (nm)

Stoke’s Shift
(nm)

Quantum
Yield ФF

Log Ԑ (M-1
cm-1)

21

-

-

-

-

-

3

267

306

39

0.05

3.3

4

273

391

118

9.24 x 10-3

3.4

22

305

369

64

0.06

4.0

8

323

423

100

0.13

3.7

9

358

408, 430

50, 72

0.10

4.2

23

356

409, 430

53, 74

0.088

4.5

15

375

459

84

0.151

4.3

16

358

410, 429

52, 71

0.105

4.9

From the absorption spectra shown in Table 3-1 and Table 3-2, it was evident that the
compounds absorbed at longer wavelengths with increase in the number of thiophene rings. In
addition to this, introduction of a carborane to the system led to a red shift in absorption. This
can be attributed to the fact that carborane cages are aromatic 3-D structures, therefore, there is
an increase in conjugation of the system. We also studied the quantum yields of the
oligothiophenes in different solvents. As a common practice, the determination of quantum
yields of an unknown is performed by comparing with a standard of known fluorescence33. In
our case, the quantum yields were measured at 298K, using 3-chloro-7-methoxy-4methylcoumarin ФF = 0.12 in cyclohexane) as a standard34. The general trend for the quantum
yields in DCM and MeOH was that there was an increase in quantum yield with an increase in
number of thiophene rings, and also both the closo- and nido- carboranes enhanced the quantum
yields. Interestingly, the trend was not observed with DMF as the solvent. In this case, the closo100

carborane was observed to enhance the quantum yield, while the nido-carborane dimished it.
Studies have shown that in some solvents, the nido-carborane does indeed diminish the quantum
yield33. A number of factors can be responsible for this observation. The first reason is the
presence of photoinduced electron transfer in polar solvents which lead to low fluorescence
yields33, 35. Secondly, presence of hydrogen bonding in polar solvents reduces quantum yields by
enhancing the non-radiative decay33, 36.
3.6 Biological Studies
In collaboration with Dr. Xiaoke Hu, we performed in vitro studies on these compounds to
determine whether they were viable candidates for PDT and/or BNCT. The reasoning behind this
was based on the fact that thiophenes are known to have many desirable properties, including
their stability, and of course their photophysical properties, which have led to their being used in
many optical devices11. Furthermore, the presence of the boron cage substituent makes these
compounds promising candidates for boron delivery in BNCT applications. In addition to this,
the small size of the molecules will hopefully make it easy for them to cross the BBB in the
treatment of brain tumors.
The phototoxicity study on both the closo- and nido- containing oligothiophenes. This study was
important because the uptake of electronic energy of a photon by a UV-absorbing molecule
initiates photochemically damaging processes in the cells37. When a molecule absorbs a photon,
it moves from the stable singlet ground state to either a singlet excited state or a triplet excited
state. The triplet excited states have longer lifetimes than singlet excited states and hence, can
take part in various chemical reactions. An alternative route for this triplet excited state is the
transfer of triplet energy to oxygen to form singlet oxygen, 1O2, which in the case of PDT
destroys tumor cells. It is therefore important for the photosensitizer to not only be phototoxic,
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but low concentrations of the compounds are required to bring about the necessary cancerous cell
destruction. In our case, the phototoxicity assays for all the oligothiophenes were carried out in
vitro using human carcinoma HEp2 cells. After incubating the cells for 20-24 h, the cells were
exposed to low light dose (1 J cm-1), and none of the oligothiophenes were found to be cytotoxic
(see Figure 3-13). It is important for a compound that is a potential PDT photosensitizer to have
low dark toxicity, but be cytotoxic in presence of light. For the dark toxicity test, the assays for
all the oligothiophenes were carried out in vitro using human carcinoma HEp2 cells. They were
then incubated for 20-24 h. At concentrations of 10μ , all compounds were found to be nontoxic to the cells in the dark as shown in Figure 3-14. These results indicated that despite the
compounds not being potential candidates for PDT, they could potentially be used in BNCT.
From cellular uptake experiments conducted over 24 h, compound 15 was found to accumulate
faster and at a higher extent than all other compounds that were tested as shown in Figure 3-15.

Figure 3-13: Phototoxicities of Oligothiophenes 3 (red), 4 (green), 8 (blue), 9 (purple), 15
(maroon) and 16 (yellow) toward HEp2 cells using 1 J cm-1 dose light.
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Figure 3-14: Dark Toxicity of Oligothiophenes 3 (red), 4 (green), 8 (blue), 9 (purple), 15
(maroon) and 16 (yellow) toward HEp2 cells using Titer Blue assay.

Figure 3-15: Time-dependent uptake for oligothiophenes 4 (green), 8 (blue), 9 (purple), 15
(maroon) and 16 yellow) at 10μ by HEp2 cells.

It is important to study the intracellular localization of compounds to evaluate their potential for
tumor destruction. In our study, the subcellular localization of compounds 3, 4, 8, 9, 14, and 15
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in HEp2 cells was studied. At concentrations of 10 μ , the compounds were allowed to incubate
overnight and thereafter evaluated by fluorescent microscopy (see Figures 3-16, 3-17 and 3-18).
Table 3-4: Summary of subcellular localization sites of oligothiophenes
Compound Media/solvent

Sub-cellular localization

3

DMSO/Cremophor

Mitochondria, Golgi, Lysosome

4

DMSO/Cremophor

Mitochondria, Golgi, Lysosome

8

DMSO/Cremophor

ER (small part), Lysosome (small part), Mitochondria,
Golgi

9

DMSO/Cremophor

Mitochondria, Lysosome, Golgi

15

DMSO/Cremophor

ER (small part), Golgi, Lysosome, Mitochondria

16

DMSO/Cremophor

Mitochondria, Golgi, Lysosome (part)

3

4

Figure 3-16: Subcellular localization of 3 and 4 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of 3 and 4 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with 3 and 4. Scale bar: 10 μ .
104

8

9

Figure 3-17: Subcellular localization of 8 and 9 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of 8 and 9 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with 8 and 9. Scale bar: 10 μ .

15

16

Figure 3-18: Subcellular localization of 15 and 16 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of 15 and 16 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with 15 and 16. Scale bar: 10 μ .
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As previously discussed, all oligothiophenes were foud to emit at wavelengths between 322 and
459, as shown in Tables 3-1, 3-2 and 3-3. However, when carrying out the sub-cellular
localization studies, it was observed that all the studied oligothiophenes emitted at wavelengths >
500 nm. A possible explanation for this observation could be that in cell media, these
oligothiophenes undergo some form of polymerization so that they form more conjugated
systems, which emit at longer wavelengths than the corresponding oligothiophenes. Further
studies are currently going on to establish the reason behind this behavior.
3.7 Conclusions
Synthesis of various caboranyl-substituted oligothiophenes was successfully carried out. The
compoundss were purified using silica gel chromatography and obtained in good yields.
Complexation of the open cage carborane derivatives with Co and Ni afforded the highly stable
Co- and Ni- bis(dicarbollide) compounds respectively. A study on the photophysical properties
of the oligothiophenes revealed that the wavelength of absorption increases with an increase in
the number of thiophene rings. In addition it was observed that the nido-carborane containing
oligothiophene absorbed at longer wavelength and recorded higher quantum yields than the
closo-carborane containing oligothiophenes. However, the effects of solvent polarity on the
quantum yields was observed when DMF was used. It was observed that in DMF, the nidocarborane containing oligothiophenes recorded lower quantum yields than their corresponding
closo-caborane containing oligothiophenes. From the biological data obtained, we noted that the
synthesized oligothiophenes were potential candidates for use in BNCT. Further work is being
carried out by our group to help us understand why the oligothiophenes emit at longer
wavelengths in cells as observed during in vitro cell studies.

106

3.8 Experimental
General Procedure
All reactions were monitored by thin layer chromatography (TLC) using 0.25mm silica gel plates
purchased from Sorbent technologies, with or without UV indicator (60F-254). All column
chromatographies were run using silica gel, 32-63μm from Sorbent Technologies. 1H and

13

C

NMR spectra were obtained either on a DPX-250 or AV-400 Bruker spectrometer. Chemical
shifts δ) are given in ppm relative to CDCl3 (7.26ppm, 1H; 77.2ppm,

13

C), or acetone-d6

(2.05ppm, 1H; 54.0ppm 13C). MALDI-TOF mass spectra were obtained on a Bruker OmniFLEX
MALDI-TOF mass spectrometer. ESI-TOF was obtained on Agilent 6210. Reagents and
solvents were obtained from either Sigma-Aldrich or Fischer Scientific, and were used without
further purification. Decaborane was obtained from Katchem, Inc. (Czech Republic) and all
other reagents were obtained from Sigma-Aldrich and used without further purification.

UV-Visible Spectroelectrochemistry
UV-visible absorption spectra were recorded on a Shimadzu Multispec-1501 spectrophotometer
(190-1100 nm scan range) using quartz SUPRASIL cells (1 cm). The polymer films were grown
on an indium tin oxide (ITO)-coated glass slide electrode.

Computational Analysis
Density functional theory (DFT) calculations and performed with the hybrid Becke threeparameter exchange functional and the Lee-Yang-Parr nonlocal correlation functional (B3LYP)
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implemented in the Gaussian 03 (Revision D.02), program suite using the LanL2DZ basis set.
The figures were generated with MOLEKEL 4.328c.

Conducting Probe Atomic Force Microscopy (AFM)
Samples of doped and undoped cobaltabisdicarbollide-functionalized polythiophene films were
prepared on gold surfaces on glass using controlled potential electropolymerization. The
substrates have a gold coating (1000 Å) on a 50 Å layer of Cr formed on glass. Surface
characterizations were accomplished in ambient conditions using a model 5500 scanning probe
microscope (SPM). Characterizations of the surface morphology were carried out using tapping
mode atomic force microscopy (AFM). Monolithic silicon probes (PPP-NCL) were used for
tapping mode experiments. A multipurpose SPM scanner with was used for imaging, with
interchangeable nose cones for either tapping mode or conductive probe AFM experiments. For
current imaging and I-V measurements, a preamp is integrated within the nose cone. Conductive
probe AFM experiments were carried out using a V-shaped conductive AFM tip (CSC11/Ti-Pt,
coated with 10 nm Pt layer on a sublayer of 20 nm Ti.

Cell Culture
All tissue culture media and reagents were obtained from Invitrogen. HEp2 cells were plated on
LabTek II two chamber coverslips. They were allowed to grow for a duration of 24-48h.
Compounds being investigated were then added at 10μ

and incubated overnight. This was then

followed by the addition of the tracers, which were added concurrently with the compound for
the remainder of the incubation period. The tracers used were: BODIPY Ceramide, ERTracker
Green, LysoSensor Green and MitoTracker Green. Distribution of the compound was determined
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using a Zeiss AxioVert 200M inverted fluorescent microscope fitted with standard texas Red,
FITC, DAPI and Cy5LP filter sets.
Phototoxicity
The HEp2 cells were placed at 7500 per well in costar 96-well plate and allowed to grow
overnight. Compounds were diluted to 100μ

in medium, and then diluted to the final working

concentrations of 6.25μ . If D SO was required to dissolve the compound, a 1% DMSO
concentration was maintained throughout the experiment and dilutions by replacing the growth
medium with medium plus 1% DMSO before making dilutions) The cells were then incubated
overnight (20-24h). The loading medium was then removed and the cells were fed medium
containing 50m

HEPES pH 7.4. The plate was placed on ice. It was then exposed to a 610nm

LP filtered light from a halogen lamp for 20 minutes 1 Jcm-2). IR radiation was filtered using a
10nm water layer contained in a petri dish placed on top of the 96 well plate. The medium was
removed and cells fed medium containing 20μL CellTiter Blue per 100μL medium and then
incubated for 4 hours. This was followed by conversion of the substrate by viable cells which
was measured by fluorescence..
Dark Toxicity
HEp2 cells were plated at 7500 cells per well in Costar 96-well plates and allowed to grow for
48h. Compounds were diluted to 100μ

in medium, and then diluted to 6.5μ . If D SO was

required to dissolve the compound, a 1% DMSO concentration was maintained throughout the
experiment and dilutions by replacing the growth medium with medium plus 1% DMSO before
making dilutions) The cells were incubated overnight (20-24h). Loading medium was then
removed and cells were fed medium containing 20μL CellTiter Blue per 100μL medium and
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then incubated for 4h. This was followed by conversion of the substrate by viable cells which
was measured by fluorescence at 570/615nm.
Time Dependent Cellular Uptake
HEp2 cells were plated at 7500 per well on Costar 96-well dish and allowed to grow for 48h.
Compounds were diluted to a 20μ

stock in medium. Equal volume of the stock was added in

triplicate wells containing cells 100μL) to give a final concentration of 10μ . The cells were
exposed to the compounds for 1h, 2h, 4h, 8h and 24h. At the end of the incubation time, the
medium was removed and the cells washed with 200μL of PBS. After removal of PBS, the cells
and compounds were then solubilized using 100μL of 0.25% Triton X-100 in PNS. To determine
the compound concentration, fluorescence emission was read using FLUOstar plate reader using
excitation/emission wavelengths appropriate for the compound under study. The cell numbers
were quantified using the CyQuant cell proliferation assay reagent.
Synthesis of Thiophene-2-o-carborane (3)
Decarborane (2.6g, 21.26 mmol) was dissolved in 30 mL dry toluene. To this solution was added
diethylsulfide (4.22g, 46.78 mmol) and the reaction mixture allowed to stir at 40oC for 3 h, and
then at 60oC for 2h. 2-ethynylthiophene (2.3g, 21.26 mmol) was dissolved in 30 mL dry toluene
and this solution added to the decarborane solution. The final reaction mixture was allowed to
reflux for 48h. After the 48h, it was allowed to cool to room temperature, after which the solvent
was evaporated under vacuum. The resulting residue was purified by column chromatography
using 2:8 DCM/Hexane as eluent. The product was obtained as white crystals in 56% yield. 1H
NMR (CDCl3, 250 MHz) δ 7.25-7.27 (1H, m), 7.20-7.21 (1H, m), 6.90-6.92 (1H, m), 3.86 (1H,
s), 1.50-3.50 (br, 10H).

13

C NMR (CDCl3, 63 MHz) 137.2, 130.4, 128.3, 127.7, 72.4, 63.7.
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11

B

NMR (CDCl3, 128 MHz, BF3.OEt2)δ -3.3 (d, 1J(B,H) ) 146 Hz, 1B) -6.6 (d, 1J(B,H) ) 147 Hz,
1B), -10.0 to -16.0 (br m, 8B). MALDI-TOF [M + H]+ 226.3. HRMS(ESI) m/z calcd for
C6H13B10S, 226.1739; found, 226.1746.

Synthesis of Tetrabutylammonium Thiophene-2-o-nido-carborane (4)
Thiophene-2-o-carborane (0.23g, 1.02 mmol) was dissolved in 10 mL dry THF. To this solution,
2.04 mL of TBAF (1.0M in THF) was added under a nitrogen atmosphere. The reaction mixture
was stirred at 60oC for 2h and the reaction monitored by TLC to make sure no more starting
material was present. It was then poured into 50mL water and extracted with EtOAc. The
organic layers were dried over anhydrous Na2SO4. It was then filtered, and the solvent removed
under vacuum. The final residue was purified by passing through a pad of silica gel using EtOAc
as eluent. The product was obtained as a white solid in 96% yield. 1H NMR (acetone-d6, 250
MHz) δ 6.95 (1H, m), 6.74 (1H, m), 6.65 (1H, m), 3.37 (8H, m), 3.35 (1H, br),1.75 (8H, m),
1.50-3.50 (br, 9H, BH), 1.37 (8H, m, CH2), 0.91 (12H, m, CH3), -2.03-2.50 (1H, br,BH).

13

C

NMR (CDCl3, 100 MHz) 150.9, 126.3, 121.9, 121.5,60.3, 59.0, 24.0, 21.0, 19.7, 13.6. 11B NMR
(CDCl3, 128 MHz,BF3.OEt2) δ -10.0 to -16.0 (br m, 3B), -18.0 to -20.0 (br m,3B), -24.6 (d, 1J
(B,H) ) 149 Hz, 1B), -34.7(dd, 1J (B,H) ) 43.8Hz, 1J (B,H) ) 43.7 Hz, 1B), -37.6 (d, 1J(B,H) ) 138
Hz, 1B).HRMS (ESI) [M-NBu4]-m/z calcd for C6H14B9S, 214.1657; found,214.1664.

Synthesis of Tetrabutylammonium Cobalt(III) Bis-(thiophene-2-o-nido-carborane) (5)
Tetrabutylammonium thiophene-2-o-nido-carborane (0.46g, 1.00mmol), anhydrous CoCl2
(1.35g, 10.00 mmol) and tBuOK (1.12 g, 10.0 mmol), were dissolved in 10 mL of anhydrous
dimethoxyethane. The reaction was placed under nitrogen atmosphere and allowed to reflux for
30 h. It was then cooled to room temperature and the precipitate that formed filtered off. The
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filtrate was diluted using 50 mL dichloromethane and washed with n-Bu4NHSO4 aqueous
solution. The organic layers were dried over anhydrous Na2SO4 and dried under a vacuum. The
final residue was purified by column chromatography using DCM as the eluent. The product was
obtained as a yellow powder 0.25g ,70 % yield. 1H NMR (acetone-d6, 250 MHz) δ 7.23 (1H,m),
7.14 (1H, m), 6.89 (2H, m),6.76 (1H, m), 6.64 (1H, m), 4.26 (1H, s), 3.42 (8H, m), 3.23 (1H, s),
1.77 (8H,m), 1.53-3.40 (18H, br), 1.38 (8H, m), 0.95-1.01 (12H, m).

13

C NMR (CDCl3, 100

MHz) 125.7,125.8, 123.2, 59.1, 30.9, 24.1, 19.7, 13.7. 11B NMR (CDCl3, 128 MHz, BF3.OEt2) δ
9.0-30.0 (br m, max at 5.9, -0.5, -8.8 and -30.8, 18B) ppm. HRMS (ESI) [M-NBu4]- m/z calcd for
C12H26B18S2Co, 488.26; found, 488.2628.

Synthesis of ([2,2'-bithiophen]-5-ylethynyl)trimethylsilane (6)
To a mixture of 5-bromo-2,2'-bithiophene (1.0g, 4.1mmol), PdCl2(PPh3)2 (0.143g, 0.204mmol),
CuI (0.039g, 0.204mmol) in DIPA (60ml) was added TMSA (1.41ml, 10.2mmol) dropwise
under argon atmosphere. The mixture was stirred at room temperature for 6h. The reaction was
quenched by pouring into water and extracting with ethyl acetate. The organic layers were
concentrated under reduced pressure and the residue purified by column chromatography using
20%DCM in hexanes to produce 76% product as a yellow solid. 1H NMR (CDCl3, 400MHz) δ
7.24 (1H, d, J= 5Hz, ArH), 7.18 (1H, d, J= 4Hz, ArH), 7.13 (1H, d, J= 4Hz, ArH), 7.02 (2H, t,
J1= 5Hz, J2= 4Hz, ArH), 0.26 (9H, s, CH3).
Synthesis of 5-ethynyl-2,2'-bithiophene (7)
Protecting group was removed from ([2,2'-bithiophen]-5-ylethynyl)trimethylsilane, 6, (0.71g,
2.71mmol) by reacting it with K2CO3 (1.12g, 8.13mmol) at room temperature for 2h. The
reaction was quenched by addition of water. This was diluted with Et2O and washed with water.

112

The organic layer was dried over Na2SO4 and evaporated under pressure. The residue was
purified using column chromatography using 20%DCM in hexanes to produce 80% product as a
yellow solid. 1H NMR (CDCl3, 400 Hz) δ 7.25 1H, d, J= 1Hz, ArH), 7.19 (2H, m, ArH), 7.03
(2H, d, J= 4Hz, ArH), 3.41 (1H, s, CH).
Synthesis of 2,2′-Bithiophene-5-o-carborane (8)
Decarborane (0.072g, 0.57mmol), 2-ethynylbithiophene (0.062g, 0.33mmol), and dry CH3CN
(0.5ml) were dissolved in dry toluene (1.5ml). The reaction mixture was stirred at 80oC under
nitrogen atmosphere for 24h. It was then cooled to room temperature, and methanol (1.0ml)
added to the reaction mixture. It was then stirred for 30 min followed by drying under vacuum.
The final residue was purified by column chromatography using 10% DCM in hexanes as eluent.
The title compound was obtained as a light brown solid, in 70% yield. 1H NMR (CDCl3, 250
MHz) δ 7.27 (1H, d, J ) 5.10 Hz, ArH), 7.18 (1H, d, J ) 3.00 Hz, ArH), 7.09 (1H, d, J ) 3.73 Hz,
ArH), 7.03 (1H, t, J ) 4.48 Hz, ArH), 6.94 (1H, d, J ) 3.71 Hz, ArH), 3.86 (1H, s, CH), 1.50-3.50
(br, 10H, BH).13C NMR (CDCl3, 63 MHz) 140.4, 136.0, 135.2, 131.1, 128.5, 126.2, 125.3,
123.8, 72.4, 63.8. 11B NMR (CDCl3, 128 MHz, BF3.OEt2)δ -3.4 (d, 1J(B,H) ) 145 Hz, 1B), -6.5
(d, 1J(B,H) ) 141 Hz, 1B), -10.0 to -16.0 (br m, 8B). MALDI-TOF [M +H]+ 309.5. HRMS (ESI)
m/z calcd for C10H15B10S2, 307.1630;found, 307.1623.

Synthesis of Tetrabutylammonium 2,2′-Bithiophene-5-o-nido-carborane (9)
2,2′-Bithiophene-5-o-carborane (0.50g, 1.62 mmol) was dissolved in 20 mL dry THF. To this
solution, 3.24 mL of TBAF (1.0M in THF) was added under a nitrogen atmosphere. The reaction
mixture was stirred at 60oC for 2h and the reaction monitored by TLC to make sure no more
starting material was present. It was then poured into 100 mL water and extracted with EtOAc.
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The organic layers were dried over anhydrous Na2SO4. It was then filtered, and the solvent
removed under vacuum. The final residue was purified by passing through a pad of silica gel
using EtOAc as eluent. The product was obtained as a yellow solid, in 94% yield. 1H NMR
(acetone-d6, 250 MHz) δ 7.27(1H, dd, J ) 1.11 Hz, J ) 4.02 Hz, ArH), 7.08 (1H, dd, J ) 1.07Hz, J
) 2.50 Hz, ArH), 6.98 (1H, dd, J )5.04 Hz, J )1.43 Hz,ArH), 6.88 (1H, d, J ) 3.69 Hz, ArH), 6.58
(1H, d, J ) 3.73 Hz,ArH), 3.36-3.43 (8H, m, CH2), 2.87 (1H, br s, CH), 1.73-1.83(8H, m, CH2),
1.50-3.50 (br, 9H, BH), 1.35-1.46 (8H, m, CH2),0.91-1.00 (12H, m, CH3), -2.51 (br, 1H, BH).13C
NMR (acetone-d6,63 MHz) 152.1, 138.8, 133.5, 128.6, 124.3, 123.7, 123.2,122.9, 80.5, 77.1,
59.2, 24.3, 20.3, 13.8. 11B NMR (CDCl3, 128MHz, BF3.OEt2) δ -10.0 to -16.0 (br m, 3B), -18.0
to -20.0(br m, 3B), -24.6 (d, 1J (B,H) ) 149 Hz, 1B), -34.7 (dd, 1J (B,H)) 43.8 Hz, 1J (B,H) ) 43.7
Hz, 1B), -37.6 (d, 1J(B,H) ) 138 Hz,1B). HRMS (ESI) [M-NBu4]- m/z calcd for C10H16B9S2,
298.1582;found, 298.1586.

Synthesis of Tetrabutylammonium Cobalt(III) Bis(2,2′-bithiophene-5-o-nido-carborane)
(10)
Tetrabutylammonium 2,2′-Bithiophene-5-o-nido-carborane (0.022g, 0.07mmol), anhydrous
CoCl2 (0.095g, 0.73 mmol) and tBuOK (0.082 g, 0.73 mmol), were dissolved in 0.5 mL of
anhydrous dimethoxyethane. The reaction was placed under nitrogen atmosphere and allowed to
reflux for 30 h. It was then cooled to room temperature and the precipitate that formed filtered
off. The filtrate was diluted using 10 mL dichloromethane and washed with n-Bu4NHSO4
aqueous solution. The organic layers were dried over anhydrous Na2SO4 and dried under a
vacuum. The final residue was purified by column chromatography using DCM as the eluent.
Product was obtained as a dark yellow solid in 58% yield. 1H NMR (acetone-d6, 250 MHz) δ
7.19 (3H, m), 7.06 (2H, m), 6.98 (2H, m), 6.79 (2H, br s), 6.41 (1H, br s), 4.17 (1H, br s),3.32
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(1H, br s), 3.07 (8H, m), 1.60 (8H,m), 1.50-3.50 (18H, br, BH), 1.37 (8H, m),1.01 (12H, m). 13C
NMR (CDCl3, 100 MHz) 127.8, 127.5, 124.5, 123.7, 123.0, 122.9, 59.0, 43.4, 24.2, 19.6,
13.5.11B NMR (CDCl3, 128 MHz, BF3.OEt2) δ 9.0-30.0 (br m, max at 5.9, -0.5, -8.8 and -30.8,
18B) ppm. HRMS (ESI) [M-NBu4]-m/z calcd for C20H30B18S4Co, 652.2346; found, 652.2362.

Synthesis of Tetrabutylammonium Nickel(III) Bis(2,2′-bithiophene-5-o-nido-carborane)
(11)
Procedure similar to synthesis of 10. 1H NMR (acetone-d6, 400 Hz) δ 7.28 3H, m), 7.07 2H,
m), 7.02 (2H, m), 6.67 (2H, br s), 6.39 (1H, br s), 4.15 (1H, br s), 3.28 (1H, br s), 3.10 (8H, m),
1.59 (8H, m), 1.60-3.33 (18H, br), 1.29 (8H, m), 1.04 (12H, m).
Synthesis of 5-bromo-2,2':5',2''-terthiophene (12)
2,2':5',2''-Terthiophene (2.0g, 8.0mmol) was dissolved in CCL4 (80ml) and NBS (1.41g,
8.0mmol) was added to the solution. The solution was stirred for 48 h at room temperature. The
solution was then filtered through cotton wool to remove the imide. The filtrate was dried under
pressure, and resulting residue purified by column chromatography using 20% DCM in hexanes
to afford product in 76% yield as a yellow solid. 1H N R CDCl3, 400 Hz) δ 7.28 2H, m,
ArH), 7.18 (2H, m, ArH), 7.12 (1H, d, J= 4Hz, ArH), 7.03 (1H, t, J1= 4Hz, J2= 5Hz, ArH), 6.93
(IH, d, J= 4Hz, ArH).
Synthesis of ([2,2':5',2''-terthiophen]-5-ylethynyl)trimethylsilane (13)
To a mixture of 5-bromo-2,2':5',2''-terthiophene (2.0g, 6.11mmol), PdCl2(PPh3)2 (0.21g,
0.31mmol), CuI (0.06, 0.31mmol) in DIPA (120ml) was added TMSA (2.12ml, 15.28mmol)
dropwise under argon atmosphere. The mixture was stirred at room temperature for 6 h. The
reaction was quenched by pouring into water and extracted with EtOAc and dried under reduced
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pressure. Product was purified by column chromatography using 20% DCM in hexanes to afford
67% of product as a yellow solid. 1H N R CDCl3, 400 Hz) δ 7.26 2H, m), 7.15 2H, m),
7.09 (1H, d, J= 4Hz), 7.01 (1H, t, J1= 4Hz, J2= 5Hz), 6.93 (1H, d, J= 4Hz), 0.23 (9H, s)
Synthesis of 5-ethynyl-2,2':5',2''-terthiophene (14)
Protecting group was removed from ([2,2':5',2''-terthiophen]-5-ylethynyl)trimethylsilane (0.5g,
1.45mmol) by reacting it with K2CO3 (0.6g, 4.35mmol) at room temperature for 2h. The reaction
was quenched by addition of water. This was diluted with Et2O and washed with water. The
organic layer was dried over Na2SO4 and evaporated under pressure. The residue was purified
using column chromatography using 20%DCM in hexanes to produce 67% product as a yellow
solid. 1H NMR (CDCl3, 400 Hz) δ 7.23 1H, m), 7.18 1H, m), 7.07 1H, m), 7.02 2H, m),
6.98 (1H, d, J = 4Hz), 6.92 (1H, d, J = 4Hz), 3.42 (1H, s)
Synthesis of 2,2′,5′,2′′-Terthiophene-5-o-carborane (15)
Decarborane (0.12g, 0.97mmol), 5-ethynyl-2,2':5',2''-terthiophene (0.148g, 0.54mmol), and dry
CH3CN (1.48 ml) were dissolved in dry toluene (6.4 ml). The reaction mixture was stirred at
80oC under nitrogen atmosphere for 24h. It was then cooled to room temperature, and methanol
(1.0ml) added to the reaction mixture. It was then stirred for 30 min followed by drying under
vacuum. The final residue was purified by column chromatography using 10% DCM in hexanes
as eluent. Product was obtained as a yellow solid in 50% yield. 1H NMR (CD2Cl2, 300 MHz) δ
7.29 (1H, br s), 7.22 (1H, br s), 7.07 (4H, m), 6.97 (1H, br s), 3.90 (1H, s), 1.47-3.50 (br, 10H,
BH).13C NMR (CD2Cl2, 63 MHz) 140.0, 138.8, 136.7, 135.0, 134.7, 131.0, 128.2, 125.7, 125.2,
125.0, 124.8, 123.6, 72.7, 64.2. 11B NMR (CDCl3, 128 MHz, BF3.OEt2) δ -3.2 (d, 1J(B,H) ) 143
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Hz, 1B), -6.4 (d, 1J(B,H) ) 148 Hz, 1B), -10.0 to -16.0 (br m, 8B). MALDI-TOF [M + H]+ 391.3.
HRMS(ESI) m/z calcd for C14H17B10S3, 390.1468; found, 390.1475.

Synthesis of Tetrabutylammonium 2,2′,5′,2′′-Terthiophene-5-o-nido-carborane (16)
2,2′:5′,2′′-Terthiophene-5-o-carborane (0.042g, 0.108 mmol) was dissolved in 1.8 mL dry THF.
To this solution, 0.22 mL of TBAF (1.0M in THF) was added under a nitrogen atmosphere. The
reaction mixture was stirred at 60oC for 2h and the reaction monitored by TLC to make sure no
more starting material was present. It was then poured into 1.8 mL water and extracted with
EtOAc. The organic layers were dried over anhydrous Na2SO4. It was then filtered, and the
solvent removed under vacuum. The final residue was purified by passing through a pad of silica
gel using EtOAc as eluent. The product was obtained as a yellow solid in 80% yield. 1H NMR
(acetone-d6, 250 MHz) δ 7.43 (1H,d, J= 4.91 Hz), 7.25 (1H, d, J = 3.41 Hz), 7.16 (1H,d, J = 3.71
Hz), 7.05-7.08 (2H, m), 6.95 (1H, d, J =3.61 Hz), 6.59 (1H, d, J = 3.64 Hz), 3.40-3.47 (8H,m,),
3.02 (1H, br s), 1.76 (8H, m), 1.52-3.50(br, 9H), 1.39 (8H, m), 0.96 (12H, m),-2.40 (br, 1H,
BH).13C NMR (acetone-d6, 63 MHz) 152.1, 137.2,137.1, 135.2, 132.6, 128.6, 125.3, 124.9,
124.1, 123.7, 123.6,122.8, 80.8, 67.7, 59.0, 24.2, 20.0, 13.6.

11

B NMR (CDCl3,128MHz,

BF3.OEt2) δ -10.0 to -16.0 (br m, 3B), -18.0 to -20.0(br m, 3B), -24.6 (d, 1J (B,H) ) 149 Hz, 1B),
-34.7 (dd, 1J (B,H)) 43.8 Hz, 1J (B,H) ) 43.7 Hz, 1B), -37.6 (d, 1J(B,H) ) 138 Hz,1B). HRMS
(ESI) [M-NBu4]- m/z calcd for C14H18B9S3, 380.1462; found, 380.1466.
Synthesis of Tetrabutylammonium
carborane) (17)
Tetrabutylammonium

Cobalt(III)

Bis-(2,2′,5′,2′′-terthiophene-5-o-nido-

2,2′,5′,2′′-Terthiophene-5-o-nido-carborane

(0.005g,

0.013mmol),

anhydrous CoCl2 (0.0095g, 0.073 mmol) and tBuOK (0.0082 g, 0.073 mmol), were dissolved in
0.1 mL of anhydrous dimethoxyethane. The reaction was placed under nitrogen atmosphere and
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allowed to reflux for 30 h. It was then cooled to room temperature and the precipitate that formed
filtered off. The filtrate was diluted using 10 mL dichloromethane and washed with

n-

Bu4NHSO4 aqueous solution. The organic layers were dried over anhydrous Na2SO4 and dried
under a vacuum. The final residue was purified by column chromatography using DCM as the
eluent. Product was obtained as a dark yellow solid in 60% yield. 1H NMR (acetone-d6,
250MHz) δ 7.41 (2H, m), 7.26 (2H, m), 7.18 (2H, m), 7.05 (4H, m), 6.86 (2H, m), 6.55 (2H, m),
3.62 (1H, br s), 3.44 (8H, m), 3.10 (1H, br s), 1.76 (8H, m), 1.52-3.48 (18H, br), 1.39 (8H, m),
0.97 (12H, m).

13

C-NMR (CDCl3, 100 MHz) 138.1, 137.9, 135.1, 132.5, 127.5, 126.2, 124.8,

123.9, 123.5,122.7, 68.7, 58.9, 42.6, 24.2, 20.0, 13.6.

11

B NMR (CDCl3, 128 MHz,BF3.OEt2) δ

9.0-30.0 (br m, max at 5.9, -0.5, -8.8 and -30.8,18B) ppm. HRMS (ESI) [M-NBu4]- m/z calcd for
C28H34B18S6Co, 816.2129; found, 816.2115.

Synthesis of Tetrabutylammonium
carborane) (18)

Nickel(III)

Bis-(2,2′,5′,2′′-terthiophene-5-o-nido-

Procedure similar to synthesis of compound 17. 47% yield. 1H NMR (CDCl3, 400 Hz) δ 7.39
(2H, m), 7.23 (2H, m), 7.17 (2H, m), 7.07 (4H, m), 6.92 (2H, m), 6.55 (2H, m), 3.57 (1H, br s),
3.34-3.41 (8H, m), 3.07 (1H, br s), 1.69-1.78 (8H, m), 1.47-3.46 (18H, br), 1.33-1.41 (8H, m),
0.92-0.98 (12H, m). MALDI-TOF calcd for for C28H34B18S6Ni, 816.21; found 816.706.
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CHAPTER 4: SYNTHESIS OF TETRABENZOPORPHYRINS
CONJUGATED WITH POLYAMINES FOR PDT
4.1 Introduction
Porphyrins and pthalocyanines (see Figure 4-1) represent two of the most studied classes of
conjugated systems1. Because of their unique optical chemical, and photophysical properties,
these compounds have been used widely in material science2, sensing2a, 3, biomedical imaging2a,
and in medicine4. PDT and BNCT are two relatively new bimodal therapies, which require the
use of sensitizers for the treatment of cancer.

Figure 4-1: Structures of porphyrin and phthalocyanine

Studies have shown that not only can porphyrins act as photosensitizers, but they also have been
found to have a high affinity for tumor cells5. The drawback for the use of porphyrins is that at
the wavelengths at which they absorb, bodily tissues also strongly absorb light, and this limits
their clinical use1. Because of this, there have been many attempts to modify the core of the
porphyrin chromophore so as to shift their absorption to the red and near IR regions. This has led
to synthesis and investigation of new classes of porphyrins which include porphyrins isomers,
expanded porphyrins, hydroporphyrins, and π-extended porphyrins. Π-extended porphyrins make
up a class of porphyrinoid chromophores, most of which contain fused aromatic rings via the β-

124

carbon atoms, as well as π-extended porphyrins at the meso-position. Examples of the πextended porphyrins can be seen in Figure 4-2.

Figure 4-2: Examples of π-extended porphyrins1

Among the π-extended porphyrins, tetrabenzoporphyrin (TBP) has received a lot of interest. As
its name indicates, TBP contains four β,β‟-fused benzene rings onto a porphyrin macrocycle.
Incorporation of these benzene rings leads to extension of the π-conjugation, which in turn leads
to a bathochromic shift in the absorption1. These optical properties make TBP promising
candidates for PDT, as well as in electronic devices and sensors. The first ZnTBP, 5, was
synthesized by Helberger and co-workers (see Scheme 4-1). They reacted o-cyanoacetophenone
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with different phthalimidines to accomplish this6. Because of its physicochemical properties,
TBP drew a lot of attention in the research world, as different groups came up with different
procedures for synthesizing them. Linstead and co-workers prepared ZnTBP 5 from ocyanocinnamic acid and also from 3-carboxymethylphthalimidine7. Vogler and Kunkely later
came up with a different procedure for the same TBP which required reaction of 2-acetylbenzoic
acid, 6, with zinc acetate in aqueous ammonia in the presence of molecular sieves at 400 oC8.
Remy also prepared 5 by reacting isoindole 7 with formaldehyde at 375oC9. One thing all these
procedures have in common is the fact that they all require harsh conditions, of heating at 300oC
often in the presence of an acid. This made the synthesis of functionalized TBPs challenging and
also led to low yields.

Scheme 4-1: Different synthetic routes to ZnTBP, 5
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Milder synthetic methods have since been explored10. Recently, Beletskaya and co-workers came
up with a method for the synthesis of TBP from 4,7-dihydroisoindole11. Using standard BartonZard chemistry, 4,7-dihydroisoindole11 was synthesized from (trimethylsilyl)acetylene,
tosylacetylene and 1,3-butadiene. It was then successfully used in the preparation of TBPs using
standard Lindsey protocol11 as shown in Scheme 4-2.

Scheme 4-2: Mild synthetic route of synthesizing TBPs11

127

One of the main areas of concern has been the low solubility of the TBPs. These compounds, for
example 5, have been found to be insoluble in most organic solvents, which has further led to
problems with their purification. One way in which this problem can be overcome is by
introduction of substituents to increase solubility12.
4.2 Polyamine Conjugated TBPs in PDT
PDT is a bimodial treatment which combines the applications of a photosensitizer and visible
light to destroy cancerous cells13. It is based on two biological properties of PDT drugs; their
selective accumulation into cancer cells and the photoactivation of the photosensitizer by visible
light in the presence of oxygen. The singlet oxygen that is generated kills the abnormal tissues 14,
while sparing the normal adjacent cells15. Photofrin®, a first generation photosensitizer has been
used in several countries to treat various cancers15. It however suffers several drawbacks, which
include poor selectivity, leading to death of the surrounding normal cells and also
photosensitivity of the skin due to slow clearance rate of the photosensitizer, which may last for
several weeks after treatment16. Other drugs that have been developed and approved in different
countries are Foscan®, which is used in treatment of head and neck cancer14a and Visudyne®
which was approved for the treatment of age related macular degeneration13. To improve the
efficiency of PDT, it is crucial to develop drugs with improved selectivity for tumor cells.
Porphyrin polyamine conjugates present a promising way to overcome this problem15.
4.2.1 Functions of Polyamines
Polyamines are components of all cells that are required for cell growth and survival. Because
they play a critical role in cell proliferation, agents that interfere with polyamine metabolism
have been developed and studied as potential anti-tumor drugs17. Interrupting the polyamine
metabolic pathway leads to either cessation of cell growth or cell destruction18. In mammalian
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cells, the polyamines spermine, spermidine and putrescene (see Figure 4-3), together with Mg2+
are the main cations in cells. The polyamine levels in cells are regulated by biosynthesis,
degradation and transport19. Uptake of polyamines increases in rapidly proliferating cells16a.
Therefore, tumor cells whereby the polyamine requirements surpass their biosynthetic abilities,
use the polyamine transport system (PAT) to fulfill their needs. PAT displays a high affinity for
polyamines and at the same time a low specificity for them. It therefore affords selective
accumulation of polyamine analogues in cancerous tissue, and in turn presenting attractive anticancer chemotherapeutic strategies14a, 16a.

Figure 4-3: Polyamines found in mammalian cells

Various research groups have shown that polyamine conjugation can be utilized to convey
cytotoxic drugs into rapidly growing cells14a,

20

. Cohen and co-workers showed that

chlorambucil-spermidine conjugate showed greater anti-tumor activity both in vivo and in vitro
than chlorambucil on its own20a. Papadopoulou and co-workers also demonstrated that
nitroimidazole-based polyamine derivatives could be of great interest as cytotoxins and
radiosensitizers for their selective uptake by tumor cells through PAT20c. Sol and co-workers
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have also done extensive research on porphyrin-polyamine conjugates for PDT and DNA
cleavage. Their studies further indicated the importance of amphiphilicity for photodynamic
activity by the porphyrin-polyamine conjugates14a.
In our research, we focus on the synthesis of TBP. As mentioned before, these compounds are
known to absorb and emit at longer wavelengths than regular porphyrins. This is critical in the
development of a photosensitizer that will be used in PDT. We employed a mixed condensation
strategy in the preparation of mono- and di-substituted TBPs. In addition, we conjugated the
TBPs to the polyamines spermine and spermidine, using a short and flexible carbon chain spacer.
We carried out in vitro studies of these conjugates, and also studied their photophysical
properties.
4.3 Results and Discussion
From the preliminary results obtained by Dr. Martha Sibrian-Vasquez, it was observed that the
mono-substituted TBP-spermine conjugate recorded low dark toxicity (See Appendix). In
addition, when exposed to light, it was found to be highly phototoxic, with an IC 50 value of
1.95μ

at 1 J/cm light dose. Furthermore, the mono-substituted TBP-spermine conjugate

recorded the fastest and highest cellular uptake of all conjugates tested. So with this in mind, we
set out to synthesize the di-substituted TBP-spermine conjugates to establish whether it would
show even better in vitro results.
We began the synthesis with the preparation of the polyamines. We started with the protection of
spermine using Boc-ON in the presence of triethylamine. Three equivalents of protecting group
were used to ensure only the terminal amines and one secondary amine reacted leaving one
secondary amine unreacted. This afforded compound 14 in 92% yield as shown in Scheme 4-3.
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The next step was introduction of the flexible spacer using N-(4-bromobutyl)phthalimide in the
presence of base. The target compound 16, was obtained after cleaving the phthalimide-protected
amine group using hydrazine monohydrate.
The synthesis of porphyrins 17-19 was carried out by a former group member, Dr. Martha
Sibrian-Vasquez. After carrying out a condensation reaction using Lindsey‟s method, using
butanopyrrole, benzaldehyde and methyl 4-formylbenzoate, she obtained the mono-substituted
product 17, and a mixture of the di-substituted products 18 and 19 (See Scheme 4-4).

Scheme 4-3: Synthesis of Boc-protected spermine 16

Starting with the mixture of substituted products, 18 and 19, we attempted to separate the two
isomers using column chromatography. This proved to be futile, as the two isomers have similar
Rf values. We therefore decided to take the mixture of isomers to the next step. We carried out
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the oxidation of the macrocycle, using DDQ, to give the fully conjugated TBPs, 20 and 21. At
this stage, it was then possible to separate the two isomers using silica gel chromatography to
afford the two isomers 20 and 21 (see Scheme 4-5). The next step was the removal of Cu metal.
This was achieved by dissolving the TBPs in concentrated H2SO4, and allowing the solution to
stir for 10 minutes. The use of H2SO4 in this case was based on the fact that these TBP-Cu
complexes belong to the class I porphyrins that are considered to be extremely stable, and
therefore require a strong acid to remove the Cu metal. Purification of 22 and 23 involved
filtration of the precipitate, and washing it with a large amount of water.
The next step was the hydrolysis of the ester groups. This was carried out by refluxing the TBP
in NaOH solution to afford the final TBPs, 24 and 25, in quantitative yields.

Scheme 4-4: Synthesis of mono- and di-substituted TBP precursors.
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Scheme 4-5: Synthesis of di-substituted TBPs 24 and 25.

Several attempts were made to conjugate the Boc-protected spermine to TBPs 24 and 25. In the
first attempt, we carried out the conjugation reaction in the presence of DIEA, HOBt, and TBTU,
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with DMF as the reaction solvent. Unfortunately, we did not get the target compounds, and we
could not correctly assign the product from NMR or MS (see Scheme 4-6).

Scheme 4-6: First Attempt Synthesis of TBP-polyamine conjugates

In order to facilitate the coupling reaction, we decided to introduce a glycine spacer (see Scheme
4-7). We started by reacting the TBPs with Boc-protected glycine in the presence of DIEA,
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HOBt, TBTU and with DMF as the reaction solvent. Unfortunately, purification of the product
proved to be difficult because of presence of DIEA which was difficult to separate.

Scheme 4-7: Synthesis of TBP-Boc-protected glycine conjugates 26 and 27

We are currently trying to purify 26 and 27. After we obtain the pure compounds, we will
deprotect the Boc groups using TFA. This will be followed by conjugation of the TBPs with the
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already synthesized Boc-protected spermine 16. Finally, we will deprotect the Boc- groups to
obtain the final compounds 28 and 29, as shown in Scheme 4-8.

Scheme 4-8: Synthesis of conjugates 28 and 29.

We decided to prepare the TBPs using a different synthetic route11. Our objective was to
determine whether we could get better yields than before. In addition, we anticipate that we will
get fewer products, which will make the isolation and purification of the desired products easier.
It will still be a mixed condensation but starting with 4,7-dihydro-2H-isoindole, rather than
butanopyrrole as in Scheme 4-4. We began the synthesis by preparing acetylene sulfone 2821 (see
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Scheme 4-9). This was done by deprotecting the trimethylsilane group using NaF at room
temperature, to afford 30 at 47% yield. Studies have shown that tosylacetylene is a strong
dienophile, that readily reacts with electron-rich dienes11, 22. The next step was a Diels- Alder
reaction, which involved reaction of the highly reactive acetyl sulfone with 1,3-butadiene at
room temperature for 48 h, to afford the cyclohexadiene, 31, in 80% yield11. We are still working
on completing the synthesis. In the next step of the synthesis we will use standard Barton-Zard
chemistry, using compound 31 for the preparation of 32 (see Scheme 4-10). Compound 32 will
then be used for the preparation of 4,7-dihydroisoindole 33, which will finally be used in the
synthesis of TBP 22 and 23 using standard Lindsey protocol.

Scheme 4-9: Synthesis of 1-(cyclohexa-1,4-dien-1-ylsulfonyl)-4-methoxybenzene, 29

Scheme 4-10: Synthesis of TBPs 22 and 23.
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4.4 Conclusions
Synthesis of the Boc-protected spermine 16 was carried out successfully. Purification of the
intermediate steps was easily achieved using silica gel chromatography and the target compound
obtained in good yields. In addition, synthesis of the di-substituted TBP isomers 24 and 25 was
successfully carried out. Similarly, purification involved silica gel chromatography using
differemt EtOAc/Hexane solvent systems for elution. Future work which entails completion of
TBP synthesis using the alternative route is currently underway. Furthermore, optimization of
reaction conditions to obtain the TBP-spermine conjugates is also underway.

4.5 Experimental
General Procedure
All reactions were monitored by use of thin layer chromatography (TLC) using 0.25mm silica
gel plates purchased from Sorbent technologies, with or without UV indicator (60F-254). All
column chromatographies were run using silica gel, 32-63μm from Sorbent Technologies. 1H
and

13

C NMR spectra were obtained either on a DPX-250 or AV-400 Bruker spectrometer.

Chemical shifts δ) are given in ppm relative to CDCl3 (7.26ppm, 1H; 77.2ppm, 13C), or acetoned6 (2.05ppm, 1H; 54.0ppm
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C). MALDI-TOF mass spectra were obtained on a Bruker

OmniFLEX MALDI-TOF mass spectrometer. ESI-TOF was obtained on Agilent 6210. Reagents
and solvents were obtained from either Sigma-Aldrich or Fischer Scientific, and were used
without further purification.
Synthesis of Compound 14
Spermine (1.0g, 4.94 mmol) was dissolved in anhydrous THF (40 mL). The solution was then
cooled to 0oC. Boc-ON (3.7g, 14.8 mmol) was dissolved in THF (40 mL) and the solution added
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dropwise to the spermine solution, under argon. Et3N (2.0g, 19.8 mmol) was added in one
portion and the reaction mixture stirred for 20h at 0oC. After 20h the solvent was evaporated
under vacuum and the residue dissolved in DCM. The resulting solution was then washed twice
with 5% NaOH, and then water. The organic phase was dried over Na2SO4, filtered and the
product purified by flash chromatography, using 20%CHCl3/Hexane. Yield 2.3g, 92%. 1H NMR
(CDCl3, 400 Hz) δ 5.24 2H, br s), 3.67 4H, m), 3.12 4H, m), 2.52 4H, m), 1.81 4H, m),
1.58 (4H, m), 1.27 (27H, s). 13C NMR (acetone-d6, 100MHz) 168.0, 78.5, 77.6, 53.2, 51.7, 46.8,
44.6, 38.8, 37.4, 36.8, 34.2, 26.5, 23.9, 23.5. ESI-TOF calcd for C25H50N4O6 502.69, found
503.38.
Synthesis of Compound 15
Boc-protected spermine (2.0g, 3.98 mmol) and N-(4-bromobutyl)phthalimide (1.35g, 4.78
mmol) were dissolved in anhydrous CH3CN (100 mL) and the reaction mixture put under argon.
K2CO3 (5.6g, 19.9 mmol) was then added to the reaction mixture in one portion, after which the
reaction mixture was refluxed for 24h. The reaction mixture was then allowed to cool to room
temperature, followed by solvent removal under vacuum. The solid residue was dissolved in
DCM and then washed twice with saturated NaHCO3, then water, and finally dried over Na2SO4.
The solvent was evaporated under vacuum, after which the product was purified by column
chromatography using 20%CHCl3/Hexane to afford 89% yield. 1H NMR (CDCl3, 400 Hz) δ
7.78 (2H, d, J= 3.5Hz), 7.66 (2H, dd, J= 3.5Hz, J= 3.5 Hz), 5.33 (2H, br s), 3.65 (4H, m), 3.38
(2H, t), 3.2 (2H, br s), 3.09 (4H, m), 2.35 (4H, m), 1.83 (4H, m), 1.60 (8H, m), 1.38 (27H, s). 13C
NMR (acetone-d6, 100MHz) 168.0, 155.7, 134.1, 132.3, 122.9, 78.5, 77.5, 58.6, 52.9, 51.5, 46.7,
44.4, 43.9, 37.3, 36.6, 33.2, 27.8, 25.7, 25.4. ESI-TOF calcd for C38H62N4O8, 703.46, found
704.46.
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Synthesis of Compound 16
Compound 15 (1.0g, 1.42 mmol) and hydrazine monohydrate (3.56g, 71.0 mmol) were dissolved
in 25 mL of a mixture of THF/MeOH (8:2). The reaction mixture was stirred under a nitrogen
atmosphere at 90oC for 5 h, and then at 50oC for 18 h. The reaction mixture was allowed to cool
to roon temperature, and the solvent was evaporated under vacuum and the residue dissolved in
CH2Cl2. The organic phase was washed with 5% aqueous NaOH (3 x 100 mL), H2O (3 x 100
mL), and finally dried over Na2SO4. The solvent was evaporated under vacuum and the product
purified by column chromatography on silica gel using 3% NH4OH/MeOH. Yield 0.39g, 48%%.
1H NMR (CDCl3, 400 Hz) δ 5.32 2H, br s), 5.30 1H, br s), 3.58 4H, m), 3.24 2H, t), 3.18
(2H, br s), 3.04(4H, m), 2.24 (4H, m), 1.80 (4H, m), 1.58 (8H, m), 1.37 (27H, s).
Synthesis of Compound 20 and 21
The mixture of isomers (0.26g, 0.258 mmol) was dissolved in 32 mL anhydrous toluene. DDQ
(0.59g, 2.58 mmol) was added to this solution and the resulting mixture refluxed for 30 minutes.
The reaction mixture was then allowed to cool to room temperature, and diluted with CHCl3. It
was then washed with saturated NaHCO3, water and finally dried over Na2SO4. The solvent was
removed under vacuum, and the resulting product purified by column chromatography using
CHCl3, to afford 0.05g and 0.086g of 20 and 21 respectively.. HRMS m/z calcd for
C64H40CuN4O4 991.2340, found 991.2325 and 991.2340 respectively.
Synthesis of Compound 22
Compound 20 (0.075g) was dissolved in concentrated H2SO4 (5 mL). The solution was allowed
to stir at room temperature for 10 minutes. It was then poured in ice/water. The resulting mixture
was extracted with CHCl3, dried over Na2SO4, and dried under reduced pressure. The final
product was purified using flash chromatography using CHCl3 to afford 80% yield. 1H NMR
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(CDCl3, 400 Hz) δ 8.67 4H, m), 8.47 6H, m), 8.03 4H, m), 7.85 4H, m), 7.45 8H, m), 7.33
(8H, m), 4.12 (6H, s). 13C NMR 167.5, 136.2, 135.9, 131.6, 131.2, 130.3, 129.5, 129.3, 124.2,
52.0. HRMS m/z calcd for C64H42N4O4 931.3279, found 931.3271.
Synthesis of Compound 23
Procedure similar for Compound 22. Starting with compound 21 (0.086g), Yield 73% 1H NMR
(CDCl3, 400 Hz) δ 8.59 4H, m), 8.42 6H, m), 8.00 4H, m), 7.90 4H, m), 7.46 8H, m), 7.30
(8H, m), 3.90 (6H, s). HRMS m/z calcd for C64H42N4O4 931.3279, found 931.3259.
Synthesis of Compound 24
Compound 22 (0.050mg, 0.054 mmol) was dissolved in 8 mL of a mixture of 1:1 2M
NaOH/THF. The mixture was refluxed for 4h. It was then allowed to cool to room temperature
and 1N HCl used to acidify the reaction mixture to pH 4-5. The precipitate that formed was
filtered and washed with water until pH was neutral. Yield 92%. 1H NMR (acetone-d6, 400MHz)
δ 10.8 2H, s), 8.45 4H, m), 8.03 6H, m), 7.56 4H, m), 7.23 4H, m), 7.18 8H, m), 7.10 8H,
m). HRMS m/z calcd for C62H38N4O4 903.2966, found 903.2970.
Synthesis of Compound 25
Procedure similar Compound 24. Starting with compound 23 (0.070g, 0.075mmol), Yield 93%.
1

H NMR (acetone-d6, 400 Hz) δ 10.7 2H, s), 8.52 4H, m), 8.05 6H, m), 7.58 4H, m), 7.27

(4H, m), 7.22 (8H, m), 7.13 (8H, m). HRMS m/z calcd for C62H38N4O4 903.2966, found
903.2961.
Synthesis of Tosylacetylene (30)
p-Tolyl-2-(trimethylsilyl)ethynyl sulfone (0.9g, 3.56 mmol) was dissolved in EtOH (18 mL) and
the solution cooled to 0oC. A chilled solution of NaF (0.45g, 10.7 mmol) in 6.75 mL water was
then added dropwise to the sulfone solution. The reaction was then allowed to warm to room
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temperature. It was allowed to stir for 3h. It was then extracted with hexane to afford the title
compound in 47% yield. 1H NMR (CDCl3, 400 Hz), δ 7.90 2H, d, J= 8Hz), 7.40 2H, d, J=
8Hz), 3.44 (1H, s), 2.48 (3H, s).
Synthesis of 1-(cyclohexa-1,4-dien-1-ylsulfonyl)-4-methoxybenzene (31)
A heavy walled pressure tube was placed in an ice/salt bath, and the temperature maintained at 10oC. 1,3-butadiene (5ml, 59.22 mmol) was the added to the flask. tolylacetylene (0.2g, 1.02
mmol) was then added to the reaction vessel, and the pressure tube sealed tight. The reaction
mixture was allowed to warm to room temperature, after which it was allowed to stir for 48h.
The reaction vessel was then cooled to -10oC for the excess 1,3-butadiene to condense back to
liquid form. It was then evaporated slowly, and the residue purified by column chromatography
using 1/10 EtOAc/hexane to afford the title compound in 80% yield. 1H NMR 7.75 (2H, d, J=
8Hz), 7.43 (2H, d, J= 8Hz), 6.99 (1H, s), 5.67 (2H, d, J= 11Hz), 2.95 (2H, s), 2.76 (2H, d, J=
8Hz), 2.42 (3H, s).
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APPENDIX: PRELIMINARY RESULTS
Preliminary results obtained by Dr. Martha Sibrian-Vasquez

Figure 5-1: Structures of studied TBPs MSV 8-90, MSV 9-28 and MSV 9-30

Figure 5-2: Phototoxicities of TBPs MSV 8-90 ■), MSV 9-28 ▲) and MSV 9-30 ▼) toward
HEp2 cells using 1 J/cm dose light.
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Figure 5-3: Dark Toxicity of TBPs MSV 8-90 ■), MSV 9-28 ▲) and MSV 9-30 ▼) toward
HEp2 cells using Titer Blue assay.

Figure 5-4: Time-dependent uptake for TBPs MSV09-28 ■) and MSV 09-30 ▲) at 10μ
HEp2 cells.
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MSV8-90

MSV 9-28

Figure 5-5: Subcellular localization of MSV 8-90 and MSV 9-28 in HEp2 cells at 10μ for 24
h. (a) Phase contrast, (b) overlay of MSV 8-90 and MSV 9-28 and phase contrast, (c) ER-tracker
green fluorescence (e) MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i)
BODIPY Ceramide fluorescence, (d), (f), (j) overlays of organelle tracers with MSV 8-90 and
MSV 9-28. Scale bar: 10 μ .
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MSV 9-30
Figure 5-6: Subcellular localization of MSV 9-30 in HEp2 cells at 10μ for 24 h. a) Phase
contrast, (b) overlay of MSV 9-30 and phase contrast, (c) ER-tracker green fluorescence (e)
MitoTracker Green Fluorescence (g) LysoSensor Green fluorescence, (i) BODIPY Ceramide
fluorescence, (d), (f), (j) overlays of organelle tracers with MSV 9-30. Scale bar: 10 μ .
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